Eric L. Garland, Ph.D., L.C.S.W.

CURRICULUM VITAE

PROFESSIONAL/RESEARCH INTERESTS

• Clinical research and treatment of addiction, chronic pain, and stress-related health conditions, including affective disorders, post-traumatic stress, and health consequences of allostatic load (e.g., cancer; irritable bowel syndrome, etc.)
• Mindfulness meditation and other mind-body interventions (e.g., CBT, clinical hypnosis)
• Integrative medicine and behavioral medicine
• Translational research using cognitive neuroscience to inform treatment development
• Self-transcendence and its prosocial consequences, including empathy and compassion
• Psychedelic-assisted psychotherapy
• Positive emotionality, resilience, and human flourishing
• Heart rate variability, autonomic psychophysiology, and electroencephalography
• Transdiagnostic, cognitive-affective mechanisms in psychopathology, including attention regulation, automaticity, appraisal, emotion regulation, and reward processing

EDUCATION

Post-doctoral Fellowship in Integrative Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 2010.

Ph.D. (with distinction), Social Work, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2009.

M.S.W., Social Work, West Virginia University, Division of Social Work, Morgantown, WV,
2003.

B.A. (magna cum laude), Psychology, Minors: Anthropology, Religious Studies, University of Delaware, Newark, DE, 1998.

CURRENT ACADEMIC POSITION

Endowed Professor in Health Sciences, T. Denny Sanford Institute for Empathy and Compassion, University of California San Diego, 2024 to present

Professor, Department of Psychiatry, University of California San Diego, 2024 to present

Distinguished Professor, University of Utah, Salt Lake City, UT, 2021 to 2024

Distinguished Endowed Chair in Research, College of Social Work, University of Utah, Salt
Lake City, UT, 2019 to 2024

Associate Dean for Research, College of Social Work, University of Utah, Salt Lake City, UT, 2015 to 2024

Professor, College of Social Work, University of Utah, Salt Lake City, UT, 2016 to 2024

Director, Center on Mindfulness and Integrative Health Intervention Development (C-MIIND), University of Utah, Salt Lake City, UT, 2017 to 2024

Associate Director of Integrative Medicine, Supportive Oncology & Survivorship Program, Huntsman Cancer Institute, Salt Lake City, UT, 2013 to 2024

Research Health Scientist, Whole Health, Salt Lake Veterans Administration Medical Center, Salt Lake City, UT, 2020 to 2024

PAST ACADEMIC POSITIONS

Assistant Director, Trinity Institute for the Addictions, College of Social Work, Florida State University, Tallahassee, FL, 2012-2013.

Assistant Professor, College of Social Work, Florida State University, Tallahassee, FL, 2010 to 2013.

Research Professor, School of Social Work, University of North Carolina at Chapel Hill, NC, 2010 to 2013.

Lecturer, School of Social Work, University of North Carolina at Chapel Hill, NC, 2006 to 2010.

GRANTS

FUNDED RESEARCH (Total $91,079,256)

1. Principal Investigator (Garland): Targeting Treatment-Resistant OUD with Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement. National Institute on Drug Abuse (UG3DA062106). MPI: Edward Nunes. ($1,837,542). 2024-2026.
2. Multiple Principal Investigator (Garland): Enhanced Pain Coping in Cancer (EPIC). National Cancer Institute (R01CA285746-01A1). MPI: Jun Mao, Adam Hanley. ($3,511,677). 2024-2029.
3. Principal Investigator (Garland): Optimizing Patient-Centered Opioid Tapering with Mindfulness-Oriented Recovery Enhancement. National Institute on Drug Abuse (R01DA058621). MPI: Nina Cooperman. ($5,650,877). 2023-2028.
4. Principal Investigator (Garland): Analgesic and Opioid Sparing Brain Mechanisms of Mindfulness-Oriented Recovery Enhancement for Chronic Low Back Pain. National Center for Complementary and Integrative Health (1R01AT011772-01A1). MPI: Fadel Zeidan. ($2,924,245). 2022-2027.
5. Multiple Principal Investigator (Garland): Implementation and Effectiveness of Mindfulness- Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use Disorder. National Institute on Drug Abuse (1R01DA056537-01). MPI: Nina Cooperman. ($3,361,632). 2022-2027.
6. Multiple Principal Investigator (Garland): Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement for Tobacco Dependence and Other Drug use in Methadone Treatment. National Institute on Drug Abuse (1R01DA057631-01). MPI: Nina Cooperman ($2,300,742). 2022-2025.
7. Principal Investigator (Garland): SMART Embedded Intervention for Military Postsurgical Engagement Readiness (SEMPER). Department of Defense, Congressionally Directed Medical Research Program – Peer Reviewed Medical Research Program – Clinical Trial Award (PR203509, W81XWH-20-PRMRP-CTA). MPI: Adam Hanley, Dan Rhon. ($4,996,715). 2021-2025.
8. Co-Investigator (Garland): Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in OUD. National Institute on Drug Abuse (1R61DA059906-01A1). PI: Suchismita Ray & Helen Fox. ($812,516). 2024-2026.
9. Site Principal Investigator (Garland): Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder. National Institute on Drug Abuse (R44DA053848). PI: Risa Weisberg. ($2,630,352). 2021-2025.
10. Multiple Principal Investigator (Garland): Neural Mechanisms Mediating Appetitive Regulation in Smoking and Nicotine Addiction. National Institute on Drug Abuse – Behavioral and Integrative Treatment Program (R01DA048094). MPI: Brett Froeliger, Michael Saladin. ($2,277,413). 2019 – 2024.
11. Multiple Principal Investigator (Garland): Pointing Beyond the Pain Perception Box: Treating Chronic Pain by Modulating Phenomenological and Psychophysiological Indices of Self-Transcendence. Tiny Blue Dot Foundation. MPI: Adam Hanley. ($862,622). 2023-2026.
12. Principal Investigator (Garland): Maximizing Mindfulness-Oriented Recovery Enhancement with Psychedelic Assisted Psychotherapy. Tanya & Richard Andrew (donors). ($220,000). 2020-present.
13. Co-Investigator (Garland): Noninvasive Targeted Treatment of Addiction: Ultrasonic Neuromodulation of Deep Neural Circuits. Wellcome Trust. MPI: Brian Mickey, Jan Kubanek, Taylor Webb. ($2,235,935). 2024 – 2027.
14. Co-Investigator (Garland): Massage for GAD: Neuroimaging and Clinical Correlates of Response. National Center for Complementary and Integrative Health (R21AT011940). PI: Mark Rappaport. ($423,500). 2023-2024.
15. Co-Investigator (Garland): Music Therapy for Opioid or Stimulant Use Disorder. Indiana Family and Social Services Administration, Division of Mental Health and Addictions via the State Opioid Response, CFDA#93.788 PI: Debra Burns. ($103,284). 2023-2024. 
16. Consultant (Garland): Music Mechanisms and Technologies Network: Integrative Models to Address Pain Through Music. (U24AT012602). PI: Debra Burns. ($2,421,333). 2023-2028.
17. Co-Investigator (Garland): Physical Therapy Integrated with Mindfulness for Patients with Chronic Musculoskeletal Pain and Long-Term Opioid Treatment. National Center for Complementary and Integrative Health (R01AT012229). PI: Jake Magel. ($1,601,952). 2023-2025.
18. Co-Investigator (Garland): Mindful Interoceptive Mapping: Elucidating a Novel Mechanism for Treating Opioid Misuse and Chronic Pain. National Institute of Drug Abuse (R21DA050792). PI: Adam Hanley. ($434,365). 2021-2023.
19. Principal Investigator (Garland): Targeting Hedonic Dysregulation to Address Chronic Pain and Opioid Misuse in Primary Care. National Institute on Drug Abuse – Behavioral and Integrative Treatment Program (R01DA042033). ($2,828,034). 2016-2022.
20. Principal Investigator (Garland): Targeting Chronic Pain and Co-Occurring Disorders in the Community with Mindfulness-Oriented Recovery Enhancement. Department of Defense, Congressionally Directed Medical Research Program – Peer Reviewed Medical Research Program – Clinical Trial Award (PR151790; W81XWH-16-1-0522). ($3,434,996). 2016 – 2022.
21. Principal Investigator (Garland): A Comparative Effectiveness Randomized Controlled Trial of Mindfulness Meditation versus Cognitive Behavioral Therapy for Opioid-Treated Chronic Low Back Pain. Patient Centered Outcomes Research Institute (PCORI) – Clinical Strategies for Managing and Reducing Long-Term Opioid Use for Chronic Pain. MPI: Aleksandra Zgierska, Robert Edwards. (OPD-1601-33860). ($9,154,507). 2017-2022. 
22. Principal Investigator (Garland): Effects of Mindfulness-Oriented Intervention on Endogenous Opioid Mechanisms of Hedonic Regulation in Chronic Pain. NIH-National Center for Complementary and Integrative Health (R61), Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics. MPI: Jon-Kar Zubieta. (R61AT009296). ($830,946). 2016-2019.              
23. Principal Investigator (Garland): Heart Rate Variability-Informed Mobile Health Research to Promote Mindfulness Skills. University of Utah Seed Grant ($9000). 2020-2021.
24. Co-Investigator (Garland): Neuroimaging Response Inhibition and Salience Attribution Changes during Mindfulness-Based Treatment of Human Heroin Addiction. National Center for Complementary and Integrative Health (R01). PI: Rita Goldstein. (R01AT010627). ($3,775,359). 2019-2024.
25. Co-Investigator (Garland): Separate and Combined Effects of Mindfulness Meditation and Savoring on Pain-Related Corticostriatal Function. National Center for Complementary and Integrative Health (R61). PI: Patrick Finan. (R61AT010134). ($1,005,568). 2019-2021.
26. Co-Investigator (Garland): Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain Management. National Center for Complementary and Integrative Health (R21/R33). PI: Nina Cooperman. (R21AT010109). ($1,819,967 for R21 and R33 phases combined). 2019-2021.
27. Co-Investigator (Garland): Understanding and Restoring Dopaminergic Function in Fibromyalgia Patients using a Mindfulness-Based Psychological Intervention: A Raclopride PET-study. Swiss National Science Foundation. PI: Chantal Martin-Soelch (182766). ($700,000 Swiss Francs). 2019-2023.
28. Co-Investigator (Garland): A Randomized Controlled Trial of Pre-Surgery Opioid Medication Effects. South/East Norwegian Hospital Trust. PI: Gernot Ernst & Siri Leknes. ($2,352,000 Norwegian Kroner). 2020-2024.
29. Co-Investigator (Garland): Understanding Postoperative Opioid Use and Misuse in Norway: A Prospective Clinical Study.  PI: Siri Leknes. ($3,375,000 Norwegian Kroner). 2020-2023.
30. Co-Investigator (Garland): SMART Stepped Care Management for Low Back Pain in Military Health System. National Center for Complementary and Integrative Health and Department of Defense. PI: Julie Fritz/Dan Rhon. (UG3AT009763). ($6,438,846). 2017 – 2023.
31. Co-Investigator (Garland): Nonpharmacologic Pain Management for Lumbar Surgery. National Center for Complementary and Integrative Health. PI: Julie Fritz/Dan Rhon. (UH3AT009763-04S1). 2020-2023.
32. Co-Investigator (Garland): Optimizing Treatment Sequencing for Patients with Chronic, Nonspecific Low Back Pain. Patient Centered Outcomes Research Institute (PCORI) – Optimized Multidisciplinary Treatment Programs for Nonspecific Chronic Low Back Pain. PI: Julie Fritz.  ($9,689,014). 2018 – 2025.
33. Principal Investigator (Garland): Behavioral Interventions for Chronic Pain and Opioid-Related Problems. Fahs Beck Fund for Research and Experimentation. ($20,000). 2016 – 2018.
34. Co-Investigator (Garland): Brief Cognitive Behavioral Therapy Replication Trial. Department of Defense. PI: Craig Bryan. (W81XWH-16-R-BAA1). ($4,900,000). 2018 – 2023.
35. Consultant (Garland): Creating and Optimizing Mindfulness Measures to Enhance and Normalize Clinical Evaluation. National Center for Complementary and Integrative Health. PI: David Victorson. R01AT009539. ($3,717,633). 2017 – 2022.
36. Co-Investigator (Garland): Epigenetic and neurodevelopmental treatment targets for prenatal opioid exposure. UCP-ECHO Grant. PI: Conradt ($25,000). 2018-2019.
37. Co-Investigator (Garland): Polysubstance Exposure in Utero: Identifying Epigenetic and Neurodevelopmental Treatment Targets. Consortium for Families and Health Research Seed Grant. PI: Conradt. ($10,000). 2018-2019.
38. Principal Investigator (Garland): Targeting Military Opioid Misuse through Mindfulness-Oriented Recovery Enhancement. NIH-National Institute on Drug Abuse (R34), RFA-DA-13-013 Prevention and Health Promotion Interventions to Prevent Alcohol and Other Drug Abuse and Associated Physical and Psychological Health Problems in U.S. Military Personnel, Veterans and their Families (R34DA037005). ($670,500). 2013 – 2017.
39. Co-Investigator (Garland): Technologies for Assessing Behavioral and Cognitive Markers of Suicide Risk. Department of Defense, Psychological Health/Traumatic Brain Injury Research Program Community Partners in Mental Health – Research Award. (PT140188). PI: Brian Baucom. ($2,414,422). 2015 – 2018.
40. Co-Investigator (Garland): The Impact of a Mindfulness-Based Intervention on Opioid Misuse during Pregnancy: A Mixed Methods Pilot RCT. Mind and Life Institute. Francisco J. Varela Award. PI: Sarah Priddy ($15,000). 2017-2019.
41. Research Award (Garland, recipient). Stephanie Loker Harpst (donor). ($13,500). 2015 – 2019.
42. Co-Investigator (Garland): Dissecting De-Automatization: The Effect of Mindfulness Training on Habit Formation. Mind and Life Institute. Francisco J. Varela Award. PI: Adam Hanley ($11,637). 2015-2017.
43. Principal Investigator (Garland): Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy: Exploration of Cognitive, Affective, and Physiological Mechanisms. National Institute on Drug Abuse, RFA-DA-11-010: Support Opportunity for Addiction Research (R03DA032517). ($73,500). 2011 – 2013.
44. Co-Principal Investigator (Garland): Trauma-Informed Mindfulness-Based Stress Reduction to Promote Intra- and Interpersonal Flourishing Among Survivors of Traumatic Violence. Mind and Life Institute. 1440 Award for Real-World Contemplative Research. ($14,980). 2013 – 2014.
45. Co-Investigator (Garland): Exploration of a Will-power Model of Psychological and Biophysical Mechanisms Underlying the Role of Mindfulness in Hypertension. Multidisciplinary Support Grant, Florida State University. PI: Amy Ai. ($25,000). 2012 – 2013.
46. Principal Investigator (Garland): Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy: Exploration of Cognitive, Affective, and Physiological Mechanisms. Fahs-Beck Fund for Research and Experimentation. ($15,000). 2011 – 2013.
47. Co-Investigator & Evaluator (Garland): Triangle Network to Engage Homeless Individuals with Substance Abuse & Mental Health Disorder (Triangle ENGAGE). Substance Abuse and Mental Health Services Administration (TI 020489). P.I.: Roberts-Lewis, A. ($2,000,000). 2008-2013.
48. Principal Investigator (Garland): Mindfulness-Oriented Recovery Enhancement for Underserved Opioid Users with Comorbid Chronic Pain and Mood Symptoms: A Preliminary Exploration of Cognitive, Affective, and Physiological Mechanisms. Council on Research & Creativity Planning Grant, Florida State University. ($12,000). 2011.
49. Principal Investigator (Garland): Mindfulness-Oriented Recovery Enhancement for Underserved Opioid Users with Comorbid Chronic Pain and Mood Symptoms: A Preliminary Exploration of Cognitive, Affective, and Physiological Mechanisms. Trinity Institute for the Addictions Seed Grant, College of Social Work, Florida State University. ($5,000). 2011.
50. Principal Investigator (Garland): Targeting Cognitive, Affective, and Physiological Mechanisms in the Risk-Chain to Alcohol Dependence: The Roles of Trauma, Attentional Biases, and Heart Rate Variability Responses to Alcohol Cues. First Year Professor’s Award, Council on Research & Creativity, Florida State University. ($17,000). 2011.
51. Principal Investigator (Garland): Biopsychosocial Assessment of a Mindfulness-Oriented Cognitive Intervention for Alcohol Dependence. Francisco J. Varela Research Grant, Mind and Life Institute. ($15,000). 2008-2010. 
52. Principal Investigator (Garland): Biopsychosocial Assessment of a Mindfulness-Oriented Cognitive Intervention for Alcohol Dependence. Armfield-Reeves Innovation Grant, University of North Carolina – Chapel Hill School of Social Work. ($9,840). 2008-2010.
53. Post-doctoral Fellow (Garland): Ruth L. Kirschstein National Research Service Award Post-doctoral Research Fellowship in Complementary and Alternative Medicine (T32 AT003378-04). National Center for Complementary and Alternative Medicine. 2009-2010.
54. Pre-doctoral Fellow (Garland): Ruth L. Kirschstein National Research Service Award Pre-doctoral Research Fellowship in Complementary and Alternative Medicine (T32 AT003378-04). National Center for Complementary and Alternative Medicine. 2008-2009.
55. Principal Investigator (Garland): George Hitchings New Investigator in Health Research Award. Triangle Community Foundation. ($4000). 2007-2008.

SELECT HONORS, AWARDS & RECOGNITION

Invited to brief Addiction Treatment and Recovery Caucus of the U.S. Congress, Capitol Hill, Washington, DC (2024)

Invited keynote lecture for NIH Emotional Well-Being Network Investigator Meeting, NIH, Bethesda, MD (2024)

Appointed to FDA-Sponsored Advisory Board of Pacific Northwest Evidence-based Practice Center – “The Development of Clinical Practice Guidelines for the Assessment and Management of Acute Low Back Pain” (2024)

Briefed Rahul Gupta, MD, Director of the U.S. Office of National Drug Control Policy (2023)

Most prolific author of mindfulness research in the world, per a bibliometric analysis of mindfulness research over the past 55 years (Baminiwatta & Solangaarachchi, 2021, Mindfulness)

Distinguished Professor, University of Utah (2021)

Invited keynote lecture to speak on complementary and integrative approaches to substance use disorder treatment at Integrative Medicine Research Lecture Series (IMLS) of the National Center for Complementary and Integrative Health – NIH (2021)

Appointed to Joint American Society of Clinical Oncology-Society for Integrative Oncology Expert Panel to Develop Guideline for “Integrative Approach to Pain Management” (2020)

Appointed by NIH Director Francis Collins and NIDA Director Nora Volkow to NIH HEAL Multidisciplinary Work Group (2019)

Distinguished Endowed Chair in Research, College of Social Work, University of Utah (2019)

Best Symposium (“The role of mindfulness-based interventions in addressing the opioid crisis”) Submitted to Addiction Health Services Research conference (2019)

Madi Odette (B.S. student) awarded Undergraduate Research Scholar Designation from the University of Utah

Sarah Priddy (PhD student) awarded University Graduate Fellowship from the University of Utah

Sarah Priddy (PhD student) awarded the SSWR Doctoral Fellows Award (2019) for her dissertation proposal, “The Impact of Mindfulness-Oriented Recovery Enhancement on Opioid Misuse During Pregnancy: A Randomized Controlled Trial.” Dissertation Chair: Eric Garland

Research paper (Garland et. al, 2017, Psychotherapy and Psychosomatics) covered on website of the National Institute on Drug Abuse, 2018

Fellow, American Academy of Social Work and Social Welfare (2018)

Society for Social Work and Research Excellence in Research Award (2018) – Honorable Mention

Research paper (Garland et al., 2017, Psychopharmacology) selected for Presentation to Director of National Institute on Drug Abuse at NIDA National Advisory Council (2017)

Mary McPhee Shields Award for Faculty Excellence in Research, University of Utah (2017)

Extraordinary Faculty Achievement Award, University of Utah (2017)

Career Services Faculty Recognition Award, University of Utah (2017)

Fellow, Society for Social Work and Research (2017)

Society for Social Work and Research Excellence in Research Award (2016) – Honorable Mention

Research paper (Garland et. al, 2015, Journal of Behavioral Medicine) covered on website of the National Institute on Drug Abuse

Best Paper Presentation of the Society for Integrative Oncology (2015)

Presidential Scholar, University of Utah (2015- 2018)

Distinguished Scholar and Fellow, National Academies of Practice (2015)

Guardian of the Flame Faculty Award, Florida State University (2013)

Fellow, Mind and Life Institute (2012)

Transformation through Teaching Award, Florida State University (2012)

FSU Council on Research and Creativity First Year Professor’s Award – First Prize (2012)

Society for Social Work and Research Outstanding Dissertation Award (2011)

Outstanding Doctoral Student of 2008 – 2009. University of North Carolina at Chapel Hill School of Social Work (2010)

Best Graduate Student Oral Presentation. University Research Day, University of North Carolina, Chapel Hill, NC. (2009)

Mind and Life Summer Research Institute Fellowship. (2009; 2008; 2007)

Samuel J. Brody Scholarship. School of Social Work, University of North Carolina, Chapel Hill, NC (2008)

University Merit Award. University of North Carolina, Chapel Hill, NC (2006)

Phi Beta Kappa (1998)

Advanced Honors Certificate. University of Delaware, Newark, DE. (1998)

Psi Chi Honor Society (1998)

Dean’s List. University of Delaware, Newark DE. (1994 – 1998)

BOOKS/TREATMENT MANUALS

Garland, E.L. (2013). Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain. Washington, DC: NASW Press.
Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain and Opioid Use. New York, NY: Guilford Press.

PUBLICATIONS (Total: 262) *denotes a paper on which Dr. Garland was either the senior or lead/corresponding author

1. * Garland, E.L., Nakamura, Y., Bryan, C.J., Hanley, A.W., Parisi, A., Froeliger, B., Marchand, W.R., & Donaldson, G.W. (2024). Mindfulness-Oriented Recovery Enhancement for veterans and military personnel on long-term opioid therapy for chronic pain: A randomized clinical trial. American Journal of Psychiatry, 181, 125-134.

2. * Cooperman, N.A., Lu, S., Hanley, A.W., Puvananayagam, T., Dooley-Budsock, P., Kline, A., & Garland, E.L. (2024). Telehealth Mindfulness-Oriented Recovery Enhancement versus methadone treatment-as-usual in individuals with opioid use disorder and pain: A randomized clinical trial. JAMA Psychiatry, 81(4), 338-346. 

3. Huang, Y., Ceceli, A.O., Kronberg, G., King, S., Malaker, P., Alia-Klein, N., Garland, E.L., & Goldstein, R.Z. (2024). Association of cortico-striatal engagement during cue-reactivity, reappraisal, and savoring of drug and non-drug stimuli with craving in heroin addiction. American Journal of Psychiatry, 181(2), 153-165.

4. * Zheng, M., Hong, T., Zhou, T., Garland, E.L., Hu, Y. (2024) The acute effect of mindfulness-based regulation on neural indices of cue-induced craving in smokers. Addictive Behaviors. In press.

5. Gaylord, S., Faurot, K., Palsson, O.S., Garland, E.L., Mann, J.D., Bluth, K., & Whitehead, W.E. (2024). Mindfulness training has long-term therapeutic benefits for women with irritable bowel syndrome. Mindfulness. In press.

6. * Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: Implementing an evidence-based intervention for chronic pain, opioid use, and opioid addiction in clinical settings. British Journal of Clinical Pharmacology. In press.

7. * Cooperman, N.A., Shen, J., Gordon, A.J., Garland, E.L. (2024). Commentary with study protocol: Implementation and effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) as an adjunct to methadone treatment for opioid use disorder (IMPOWR-MORE). Substance Use and Addiction Journal. Advance online publication.

8. * Garland, E.L., Recasens, M., Taple, B.J., Donaldson, G.W., Weisberg, R.B. (2024). Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: A phase 1 trial. Annals of Medicine. In press.

9. Maylott, S.E., Reese, S.E., Zhou, A.M., Kaliush, P.R., Terrell, S. Saenz, C., Brown, L., Crowell, S.E., Lester, B., Smid, M.C., Shakib, J.H., Garland, E.L., & Conradt, E. (2024). Maternal psychophysiology profiles: associations with prenatal opioid use, maternal emotion dysregulation, and newborn neurobehavior. Pediatric Research. In press.

10. Woods, D.K., Nelson, E.O., Oakley, L.D., Kunkul, F., Barret, B.P., Hua, N., Burzinski, C.A., Garland, E.L., Zgierska, A.E. (2024). “What helps your back pain?” A qualitative analysis of self-management pain strategies in adults treated with long-term opioids for chronic low back pain. Journal of Opioid Management. In press.

11. Gullapalli, B.T., Carreiro, S., Chapman, B.P., Garland, E.L., Rahman, T. (2024). Pharmacokinetics-informed neural network for predicting opioid administration moments with wearable sensors. Proceedings of the AAAI Conference on Artificial Intelligence, 38(21), 22892-22898. https://doi.org/10.1609/aaai.v38i21.30326.

12. * Hanley, A.W., Lingard, A., Garland E.L., (2024). A single-session, 2-hour version of Mindfulness-Oriented Recovery Enhancement (One MORE) improves chronic pain patients’ pain-related outcomes through 3-month follow-up in a randomized controlled trial. Journal of Integrative and Complementary Medicine.

13. * Garland, E.L. & Jinpa, T. (2024). Mindfulness-induced self-transcendence promotes universal love with consequent effects on opioid misuse. Behaviour Research and Therapy. In press.

14. * Dmytriiev, D., & Garland, E.L. (2024). Chronic pain during 60 days of war: The impact of the Russian war on Ukranian patients. Journal of Public Health. In press.

15. Ceceli, A.O., Huang, Y., Gaudreault, P.-O., McClain, N., King, S., Kronberg, G., Brackett, A., Hoberman, G., Gray, J., Garland, E.L., Alia-Klein, N., & Goldstein, R.Z. (2024). Recovery of anterior prefrontal cortex inhibitory control after 15 weeks of inpatient treatment in individuals with heroin use disorder: a longitudinal cohort fMRI study. Nature Mental Health. In press.

16. * Cooperman, N.A., Lu, S., & Garland, E.L. (2024). Letter in reply to Hogans. JAMA Psychiatry. In press.

17. Finan, P.H., Hunt, C., Keaser, M.L., Smith, K., Lerman, S., Bingham, C., Letzen, J., Barrett, F., Garland, E.L., Zeidan, F., & Seminowicz, D.A. (2024). Effects of savoring meditation on positive emotions and pain-related brain function: A mechanistic randomized controlled trial in people with rheumatoid arthritis. Journal of Pain. In press. doi:10.1016/j.jpain.2024.01.343

18. Magel, J., Benecuik, J., Siantz, E., Fritz, J., Garland, E.L., Hanley, A., Shen, J., Blosser, P., Matev, T., & Gordon, A. (2024). PT-IN-MIND: study protocol for a multisite randomised feasibility trial investigating physical therapy with integrated mindfulness (PT-IN-MIND) for patients with chronic musculoskeletal pain and long-term opioid treatment who attend outpatient physical therapy. BMJ Open. In press.

19. Horton, D.M., Woods, D.K., Nelson, E.O., Lennon, R., Zgierska, A., Barrett, B., & Garland, E.L., & Edwards, R.R. (2024). Qualitative findings from a randomized trial of mindfulness-based and cognitive-behavioral group therapy for opioid-treated chronic lower back pain. Journal of Health Psychology. In press.

20. * Sacchet, M.D., Fava, M., & Garland, E.L. (2024). Modulating self-referential processing through meditation and psychedelics: is scientific investigation of self-transcendence clinically relevant? World Psychiatry, 23(2), 298-299.

21. Verdejo-Garcia, A., Berry, J., Caracuel, A., Copersino, M.L., Field, M., Garland, E.L., Lorenzetti, V.,  Malloy-Diniz, L., Manning, V., Marceau, E.M., Pennington, D.L., Rezapour, T., Strickland, J.C., Wiers, R.W., & Ekhtiari, H. (2024). Clinical translation of expert-endorsed cognitive rehabilitation interventions for substance use disorders. World Psychiatry, 23(2), 299-300.

22. * Parisi, A., Hudak  J., Froeliger, B., & Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement reduces posttraumatic stress by enhancing reappraisal among chronic pain patients with co-occurring opioid misuse. Nature Mental Health, 1, 489–500.

23. * Odette, M.M., Porucznik, C.A., Gren, L.H., Garland, E.L. (2023). Alcohol consumption and opioid craving among chronic pain patients prescribed long-term opioid therapy. Addictive Behaviors, 150, 107911.

24. Larsen, J.K., Holland, G.J., Garland, E.L., Evers, A.W.M., Wiers, R.W. (2023). Be more mindful: Targeting addictive responses by integrating mindfulness with cognitive bias modification or cue exposure interventions. Neuroscience & Biobehavioral Reviews, 153, 105408.

25. Paschali, M., Lazaridou, A., Sadora, S., Papianou, L., Garland, E.L., Zgierska, A.E., & Edwards, R.R. (2023). Mindfulness-based interventions for chronic low back pain: A systematic review and meta-analysis. Clinical Journal of Pain, 40(2), 105-113.

26. * Ray, S., Bhanji, J., Kennelly, N., Fox, H.C., Dooley Budsock, P., Delgado, M., Cooperman, N.A., & Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement in opioid use disorder: Extended emotional regulation and neural effects and immediate effects of guided meditation in a pilot sample. Explore. Advance online publication. https://doi.org/10.1016/j.explore.2023.11.001.
    
27. Jamison, R.N., Edwards, R.R., Brown, R., Burzinski, C.A., Lennon, R.P., Barrett, B.P., Nakamura, Y., Schiefelbein, A.R., Garland, E.L., & Zgierska, A. (2023). Risk factors for self-harm among persons on prescription opioids for chronic back pain: Hierarchical odds-ratio analyses. Clinical Journal of Pain, 39(12), 643-653.

28. Zgierska, A.E., Burzinski, C.A., Garland, E.L., Barrett, B., Lennon, R.P., Brown, R.L., Schiefelbein, A.R., Nakamura, Y., Stahlman, B., Jamison, R.N., & Edwards, R.R. (2023). Experiences of adults with opioid-treated chronic low back pain during the COVID-19 pandemic: A cross-sectional survey study. Medicine, 102(41), e34885.

29. * Parisi, A., Hudak, J., & Garland, E.L. (2023). The effects of mindfulness-based intervention on emotion-related impulsivity in addictive disorders. Current Addiction Reports.

30. * Incze, M., & Garland, E.L. (2023). Mobilizing primary care against the opioid crisis in the post X-waiver era. Journal of General Internal Medicine, 38, 3618-3620.

31. Hanley, A.W., Walker, D., Wilson Zingg, R., Garland, E.L. & Hansen, P. A. (2023). The mindful warm-up: Proof of concept for a brief embedded intervention. Mindfulness, 14(7), 1804-1812.

32. Kleinstäuber, M., Garland, E.L., Bannonc, B., Sanyer, M., Barke, A. (2023). Endorsing a biopsychosocial perspective of pain in individuals with chronic pain: Development and validation of a scale. Clinical Journal of Pain, 40(1), 35-45.

33. Lewis, B.R., Garland, E.L., Byrne, K., Durns, T., Beck, A., Thielking, P. (2023). HOPE: A pilot study of psilocybin enhanced group psychotherapy in patients with cancer. Journal of Pain and Symptom Management, 66(3), 258-269.

34. Upton, S., Brown, A.A., Golzy, M., Garland, E.L, & Froeliger, B. (2023). Right inferior frontal gyrus theta-burst stimulation reduces smoking behaviors and strengthens fronto-striatal-limbic resting state functional connectivity: A randomized crossover trial. Frontiers in Psychiatry, 14, 1166912.

35. * Garland, E.L., Fix, S.T., Hudak, J.P., Bernat, E.M., Nakamura, Y. Hanley, A.W., Donaldson, G.W., Marchand, W.R., & Froeliger, B. (2023). Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards. Psychological Medicine, 53(5), 2085-2094.

36. * Parisi, A., Zgierska, A.E., Burzinski, C.A., Lennon, R.P., Jamison, R.N., Nakamura, Y., Barrett, B., Edwards, R.R., Garland, E.L. (2023). To be aware, or to accept, that is the question: Differential roles of awareness of automaticity and pain acceptance in opioid misuse. Drug and Alcohol Dependence, 247, 109890.

37. Wang, Y., Garland, E.L., & Farb, N.A. (2023). An experimental test of the Mindfulness-to-Meaning Theory: Causal pathways between decentering, reappraisal, and wellbeing. Emotion, 23(8), 2243-2258.

38. * Garland, E.L., Gullapalli, B., Prince, K.C., Hanley, A.W., Sanyer, M., Tuomenoksa, M., & Rahman, T. (2023). Zoom-based Mindfulness-Oriented Recovery Enhancement plus just-in-time mindfulness practice triggered by wearable sensors for opioid craving and chronic pain. Mindfulness, 1-17.

39. Eikemo, M., Meier, I., Løseth, G., Trøstheim, M., Ørstavik, N., Jensen, E., Garland, E.L., Berna, C., Ernst, G., & Leknes, S. (2023). Opioid analgesic effects on subjective well-being in the operating room. Anesthesia, 78(9), 1102-1111.

40. * Tofighi, B., Marini, C., Lee, J.D., & Garland, E.L. (2023). Patient perceptions of integrating meditation-based interventions in office-based opioid treatment with buprenorphine: A mixed-methods survey. Journal of Addiction Medicine, 17(5), 517-520.

41. * Hanley, A. W., Hinich, J., Kennedy, A., Newman, C., Martorella, G., Anderson, L., Pelt, C.,  Gililland, J., & Garland, E. L. (2023). The analgesic effects of nurse-led, ultra-brief mindfulness interventions: A randomized controlled trial. Mindfulness, 1-12.

42. * Garland, E.L., & Parisi, A. (2023). Mindfulness-based treatments for addictive disorders. In Miller, S.C., Fiellin, D.A., & Rosenthal, R.N. (Eds.) American Society for Addiction Medicine (ASAM) Principles of Addiction Medicine 7^th Edition, Wolters Kluwer.

43. Palmer, A.M., Carpenter, M.J., Baker, N.L., Froeliger, B., Foster, M.G., Garland, E.L., Saladin, M.E., & Toll, B.A. (2023). Development of two novel treatments to promote smoking cessation: Savor and Retrieval Extinction Training pilot clinical trial findings. Experimental and Clinical Psychopharmacology, 32(1), 16-26.

44. Woods, D.K., Nguyen, H., Lennon, R.P., Sundaram, C., Burzinski, C.A., Garland, E.L., Zgierska, A.E., & Barrett, B. (2023). Adults with opioid-treated chronic low back pain: Qualitative analysis of the opioid medication impact. Journal of Pain Management, 16(1), 00-00.

45. * Garland, E.L., & Jenson, J. (2023). Matthew Owen Howard. Encyclopedia of Social Work. Oxford University Press.

46. * Parisi, A., Hanley, A.W., & Garland, E.L. (2023). Mindfulness-based practice. In Franklin, C., & Jordan, C. (Eds.) Social Work Treatment 7^th Edition. Oxford University Press.

47. * Garland, E.L., Roberts, L.R., Hanley, A.W., Zeidan, F., & Keefe, F.J. (2023). The Mindful Reappraisal of Pain Scale (MRPS): validation of a new measure of psychological mechanisms of mindfulness-based analgesia. Mindfulness, 14, 192-204.

48. Verdejo-Garcia, A., Rezapour, T., Giddens, E., Zoooozi, A.K., Rafei, P., Berry, J., Caracuel, A., Copersino, M.L., Field, M., Garland, E.L., Lorenzetti, V., Malloy-Diniz, L., Manning, V., Marceau, E.M., Pennington, D.L., Strickland, J.C., Wiers, R., Fairhead, R., Anderson, A., the ISAM Neuroscience Cognitive Training and Remediation Workgroup, Ekthiari, H. (2023). Cognitive training and remediation interventions for substance use disorders: A Delphi consensus study. Addiction.

49. * Garland, E.L., Hanley, A.W., Nakamura, Y., Barrett, J.W., Baker, A.K., Reese, S.E., Riquino, M.R., Froeliger, B., & Donaldson, G.W. (2022). Mindfulness-Oriented Recovery Enhancement versus supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: A randomized clinical trial. JAMA Internal Medicine, 182(4), 407-417.

50. * Garland, E.L., Hanley, A.W., Hudak, J., Nakamura, Y., Froeliger, B. (2022). Mindfulness-induced endogenous theta stimulation occasions self-transcendence and inhibits addictive behavior. Science Advances, 8(41), eabo4455.

51. Lewis, B., Byrne, K., Hendrick, J., Garland, E.L., Thielking, P., & Beck, A. (2022). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. Journal of Psychedelic Studies, 7(1), 1-11.

52. * Hudak, J., Bernat, E.M., Fix, S.T., Prince, K.C., Froeliger, B., & Garland, E.L. (2022). Neurophysiological deficits during reappraisal of negative emotional stimuli in opioid misuse. Biological Psychiatry, 12(15), 1070-1078.

53. Mao, J., Ismalia, N., Bao, T., Barton, D., Ben-Ayre, E., Garland, E.L., Greenlee, H., Leblanc, T., Lee, R.T., Lopez, A., Loprinzi, C., Lyman, G.H., Macleod, J., Master, V.A., Ramchandran, K., Wagner, L.I., Walker, E.M., Bruner, D., Witt, C.M., Bruera, E. (2022). Integrative medicine for pain management in oncology: SIO-ASCO Guideline. Journal of Clinical Oncology, 40(34), 3998-4024.

54. * Roberts, R.L., & Garland, E.L. (2022). Association between opioid use disorder and blunted heart rate variability among opioid-treated chronic pain patients. Addiction Biology, 27(6), e13230.

55. * Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: An evidence-based social work intervention for addiction, stress, and pain. Social Work, 68(2), 171-174.

56. * Redwine, L.S., Schwartz, E.R., & Garland, E.L. (2022). Mindfulness promotes positive health behaviors by enhancing self-regulation, motivation, and learning: Perspectives from research and clinical care. Journal of Integrative and Complementary Medicine, 28(11), 847-850.

57. Lazaridou, A., Paschali, M., Zgierska, A.E., Garland, E.L., & Edwards, R.R. (2022). Exploring the relationship between endogenous pain modulation, pain intensity, and depression in patients using opioids for chronic low back pain. Clinical Journal of Pain, 38(10), 595-600.

58. * Parisi, A., R.L. Roberts, Hanley, A.W., & Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement for addictive behavior, psychiatric distress, and chronic pain: A multilevel meta-analysis of randomized controlled trials. Mindfulness, 13(10), 2396-2412.

59. Herrmann, T.S., Nazarenko, E., Marchand, W., Day, A., Merrill, J., Neil, M., Thatcher, J., Garland, E.L., & Bryan, C. (2022). Randomized controlled trial of a brief mindfulness-based intervention for suicidal ideation among Veterans. Military Medicine, usac291.

60. Hanley, A.W., Mai, T. & Garland, E.L. (2022). Self-transcendent states during a modified Mindfulness-Based Stress Reduction program predict improvements in mood. Psychology of Consciousness: Theory, Research, and Practice, , 10(3), 213.

61. Fritz, J.M., Rhon, D. I., Garland, E. L., Hanley, A. W., Greenlee, T., Fino, N., Martin, B., Highland, K.B., & Greene, T. (2022). The Effectiveness of a Mindfulness-Based Intervention Integrated with Physical Therapy (MIND-PT) for Post-Surgical Rehabilitation after Lumbar Surgery: A Protocol for a Randomized Controlled Trial as Part of the Back Pain Consortium (BACPAC) Research Program. Pain Medicine, 24(Supplement_1), S115-S125.

62. * Garland, E.L., Hudak, J., & Froeliger, B. (2022). Mindfulness-Oriented Recovery Enhancement restructures reward processing in opioid misuse. Biological Psychiatry, 91(9), S88.

63. * Roberts, R.L., & Hanley, A.W., & Garland, E.L. (2022). Mindfulness-based interventions for perioperative pain management and opioid risk reduction following surgery: A stepped care approach. The American Surgeon. Online publication. https://doi.org/10.1177/00031348221114019.

64. Marchand, W.R., Zhang, C., Hamilton, C., Presson, A.P., Nelson, R., Yoo, M., Garland, E.L., Nazarenko, E., Herrmann, T. (2022). Utilization and outcomes of a Whole Health model of care by veterans with psychiatric illness. Complementary Therapies in Medicine, 71, 102884.

65. * Hanley, A. W. & Garland, E. L. (2022). Self-transcendence predicts better pre- and postoperative outcomes in two randomized clinical trials of brief mindfulness-based interventions. Mindfulness, 13(6), 1532-1543.

66. Rosky, C., R.L. Roberts, Hanley, A.W., & Garland, E.L. (2022). Mindful lawyering: A pilot study on mindfulness training for law students. Mindfulness, 13(9), 2347-2356.

67. * Parisi, A., Hanley, A.W., & Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement reduces opioid craving, pain, and negative affect among chronic pain patients on long-term opioid therapy: An analysis of within- and between-person state effects. Behaviour Research and Therapy, 152, 104066.

68. * Parisi, A., Landicho, H., Hudak, J., Leknes, S., Froeliger, B., & Garland, E.L. (2022). Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy. Drug and Alcohol Dependence, 233, 109361.

69. * Bedford, C., Nakamura, Y., Marchand, W.R., & Garland, E.L. (2022). Heightened autonomic reactivity to negative affective stimuli among active duty soldiers with PTSD and opioid-treated chronic pain. Psychiatry Research, 309, 114394.

70. Agin-Liebes, G., Weiss, B., Zeifman, R., Luoma, J.B., Garland, E.L., & Campbell, W.K. (2022). Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. Journal of Psychopharmacology, 36(3), 295-308.

71. * Sanyer, M., Odette M.M., & Garland, E.L. (2022). Trait mindfulness is associated with enhanced autonomic regulation of opioid cue-reactivity. Mindfulness, 13(3), 685-694.

72. * Roberts, R.L., Ledermann, K., & Garland, E.L. (2021). Mindfulness-Oriented Recovery Enhancement improves negative emotion regulation among opioid-treated chronic pain patients by increasing interoceptive awareness. Journal of Psychosomatic Research, 152, 110677. 

73. * Parikh, A., Moeller, S.J., & Garland, E.L. (2021). Simulated opioid choice linked to opioid use disorder severity among veterans with chronic pain: Initial validation of a novel paradigm. American Journal of Drug and Alcohol Abuse, 48(4), 403-412.

74. * Hanley, A.W., Gililland, J., & Garland, E.L. (2021). To be mindful of the breath, or mindful of pain, that is the question: Comparing two brief preoperative mindfulness techniques for total joint arthroplasty patients. Journal of Consulting and Clinical Psychology, 89(7), 590-600.

75. * Garland, E.L. (2021). Mindful positive emotion regulation as a treatment for addiction: From hedonic pleasure to self-transcendent meaning. Current Opinion in Behavioral Sciences, 39, 168-177.

76. Ledermann, K., Känel, R.V., Berna-Renella, C., Sprott, H., Burckhardt, M., Jenewein, J., Garland, E.L.,  Martin-Sölch, C. (2021). Understanding and restoring dopaminergic function in Fibromyalgia patients using a mindfulness-based psychological intervention: A [18F]-DOPA PET study Study protocol for the FIBRODOPA study- a randomized controlled trial. Trials, 22(1), 864.
    
77. * Reese, S.E., Conradt, L., Riquino, M.R., & Garland, E.L. (2021). An integrated mechanistic model of Mindfulness-Oriented Recovery Enhancement for opioid-exposed mother-infant dyads. Frontiers in Psychology, 12:688359.

78. Zgierska A.E., Burzinski C.A., Garland E.L., Lennon R.P., Jamison, R., Nakamura Y, Barrett B, Sehgal N, Mirgain SA, Singles JM, Cowan P, Woods D, Edwards RR. (2021). Mindfulness-based therapy compared to cognitive behavioral therapy for opioid-treated chronic low back pain: protocol for a pragmatic randomized controlled trial. Contemporary Clinical Trials, 110, 106548.

79. * Cooperman, N., Hanley, A.W., Kline, A., Garland, E.L. (2021). A pilot randomized clinical trial of Mindfulness-Oriented Recovery Enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being. Journal of Substance Abuse Treatment, 127, 108468.

80. * Hudak, J., Hanley, A.W., Marchand, W.R., Nakamura, Y., Yabko, B., Garland, E.L. (2021). Endogenous theta stimulation during meditation predicts reduced opioid dosing following treatment with Mindfulness-Oriented Recovery Enhancement. Neuropsychopharmacology, 46(4), 836–843.

81. Rosenthal, A., Levin, M.E., Garland, E.L., Romanczuk-Seiferth. (2021). Mindfulness in treatment approaches for addiction – underlying mechanisms and future directions. Current Addiction Reports, 8, 282-297.

82. * Hanley, A.W., & Garland, E.L. (2021). Brief preoperative mindfulness training for total joint arthroplasty patients is superior to standard preoperative care for improving postsurgical physical function. PAIN.

83. * Hanley, A.W., de Vibe, M., Solhaug, I., Farb, N., Goldin, P.R., Gross, J.J., Garland, E.L. (2021). Modeling the Mindfulness-to-Meaning Theory’s mindful reappraisal hypothesis: Replication with longitudinal data from a randomized controlled study. Stress and Health, 37(4), 778-789.

84. * Hanley, A.W., Gililland, J., Erickson, J., Pelt, C., Peters, C., Rojas, J., Garland, E.L. (2021). Brief preoperative mind-body therapies for total joint arthroplasty patients: A randomized controlled trial. PAIN, 162(6), 1749-1757.

85. * Garland, E.L. (2020). Psychosocial intervention and the reward system in pain and opioid misuse: new opportunities and directions. PAIN, 161(12), 2659-2666.

86. * Garland, E.L., & Howard, M.O. (2020). Prescription opioid misusers exhibit blunted parasympathetic regulation during inhibitory control challenge. Psychopharmacology, 238, 765-774.

87. * Hanley, A.W., & Garland, E.L. (2020). Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity. Drug and Alcohol Dependence, 217(1), 108351.

88. * Hanley, A.W., Zingg, R., & Garland, E.L. (2020). A mindfulness-based waiting room intervention for osteopathic manipulation patients: A pilot randomized controlled trial. The Journal of the American Osteopathic Association, 121, 337-348.

89. * Li, W., & Garland, E.L. (2021). Treatment and interventions for addictive behaviors in cyberspace. In Yan, Z. (ed.), Cambridge Handbook of Cyber Behavior, Cambridge University Press.

90. Hanley, A. W., Dehili, V., Krzanowski, D., Barou, D., Lecy, N. & Garland, E. L. (2021). Effects of video-guided group vs. solitary meditation on mindfulness and social connectivity: Implications for online mindfulness training. Clinical Social Work Journal, 50(3), 316-324.

91. * Hanley, A.W., & Garland, E.L. (2020). The Mindfulness-Oriented Recovery Enhancement Fidelity Measure (MORE-FM): Development and validation of a new tool to assess therapist adherence and competence. Journal of Evidence-Based Social Work, 18(3), 308-322.

92. * Hudak, J., Prince, K., Marchand, W., Hanley, A.W., Nakamura, Y., Bryan, C., Froeliger, B., & Garland, E.L. (2021). The temporal dynamics of emotion dysregulation in prescription opioid misuse. Progress in Neuropsychopharmacology and Biological Psychiatry, 104: 110024.

93. * Garland, E.L., Hudak, J., Hanley, A.W., & Nakamura, Y. (2020). Mindfulness-Oriented Recovery Enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation. American Psychologist, 75(6), 840-852.

94. * Hanley, A.W., Bernstein, A., Nakamura, Y., Hadash, Y., Rojas, J., Tennant, K., Jensen, R., & Garland, E.L. (2020). The Metacognitive Processes of Decentering Scale: Development and initial validation of trait and state versions. Psychological Assessment, 32(10), 956-971.

95. Trostheim, M.O., Eikemo, M., Meir, R., Hansen, I., Paul, E., Kroll, S.L., Garland, E.L., Leknes, S. (2020). Assessment of anhedonia in adults with and without mental illness: A systematic review and meta-analysis. JAMA Network Open, e2013233-e2013233.

96. * Garland, E.L., Brintz, C.E., Hanley, A.W., Roseen, E.J., Atchley, R.M., Gaylord, S.A., Faurot, K., Yaffe, J., Fiander, M., Keefe, F.J. (2020). Mind-body therapies for opioid-treated pain: A systematic review and meta-analysis of mental techniques to improve clinical pain and opioid-related outcomes. JAMA Internal Medicine, 180(1), 91-105.

97. Fritz, J., Rhon, D., Teyhen, D. Kean, J., Vanneman, M., Garland, E.L., Lee, I., Thorp, R., & Greene, T. (2020). A sequential multiple-assignment randomized trial (SMART) for stepped care management of low back pain in the military health system: A trial protocol. Pain Medicine, (Suppl2): S73-S82.

98. * Hanley, A.W., Dambrun. M., & Garland, E.L. (2020). Effects of mindfulness meditation on self-transcendent states: Perceived body boundaries and spatial frames of reference. Mindfulness, 11(5), 1194-1203.

99. * Garland, E.L., Atchley, R.M., Hanley, A.W., Zubieta, J.K., & Froeliger, B. (2019). Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Science Advances, 5(10), eaax1569.

100. * Garland, E.L., Hanley, A.W., Riquino, M.R., Reese, S.E., Baker, A.K., Salas, K., Yack, B.P., Bedford, C.E., Bryan, M.A., Atchley, R.M., Nakamura, Y., Froeliger, B., & Howard, M.O. (2019). Mindfulness-Oriented Recovery Enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 87(10), 927-940.

101. Jinich-Diamant, A., Garland, E.L., Baumgartner, J., Gonzalez, N., Riegner, G., Birenhaum, J., Case, L., & Zeidan, F. (2020). Neurophysiological mechanisms supporting mindfulness meditation-based pain relief: An updated review. Current Pain and Headache Reports, 24(56).

102. * Riquino, M.R., Reese, S.E., & Garland, E.L. (2020). Assessing attentional bias toward nonsuicidal self-injury cues in young adults with histories of engaging in self-harm. Child and Adolescent Social Work Journal, 38, 641-650.

103. Skolasky, R.L., Wegener, S.T., Aaron, R.V., Ephraim, P., Brennan, G., Greene, T., Lane, E., Minick, K., Hanley, A.W., Garland, E.L., Fritz, J.M. (2020). The OPTIMIZE Study: Protocol of a pragmatic sequential multiple assessment randomized trial of nonpharmacologic treatment for chronic, nonspecific low back pain. BMC Musculoskeletal Disorders, 21(1), 293.

104. * Moeller, S.J., Hanley, A.W., & Garland, E.L. (2020). Behavioral preference for viewing drug versus pleasant images predicts current and future opioid misuse among chronic pain patients. Psychological Medicine, 50(4), 644-652.

105. Adler-Neal, A.L., Waugh, C.E., Garland, E.L., Shaltout, H.A., Diz, D.I., & Zeidan, F. (2020). The role of heart rate variability in mindfulness-based pain relief. Journal of Pain, 21(3-4), 306-323, 

106. * Goldberg, S.B., Hanley, A.W., Baldwin, S.A., Bernstein, A., & Garland, E.L. (2020). Does mindfulness practice promote psychological functioning or is it the other way around? Psychotherapy, 57(3), 310-322.

107. * Garland, E.L., Hanley, A.W., Kline, A., & Cooperman, N.A. (2019). Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial. Drug and Alcohol Dependence, 201(1), 61-65.

108. * Garland, E.L., Trostheim, M., Eikemo, M., Ernst, G., & Leknes, S. (2019). Anhedonia in chronic pain and prescription opioid misuse. Psychological Medicine, , 50(12), 1977-1988.

109. * Hanley, A.W., & Garland, E.L. (2019). Mapping the affective dimension of embodiment with the Sensation Manikin: Validation among chronic pain patients and modification by Mindfulness-Oriented Recovery Enhancement. Psychosomatic Medicine, 81, 612-621.

110. * Garland, E.L., & Fredrickson, B.L. (2019). Positive psychological states in the arc from mindfulness to self-transcendence: Extensions of the Mindfulness-to-Meaning Theory and applications to addiction and chronic pain treatment. Current Opinion in Psychology, 28, 184-191.

111. * Hanley, A. W., De Vibe, M., Solhaug, I., Gonzalez-Pons, K. M., & Garland, E. L. (2019). Mindfulness Training Reduces Neuroticism over a 6-Year Longitudinal Randomized Control Trial in Norwegian Medical and Psychology Students. Journal of Research in Personality, 82, 103859.

112. * Hanley, A.W., & Garland, E.L. (2019). Spatial frame of reference as a phenomenological feature of self-transcendence: Measurement and manipulation through mindfulness meditation. Psychology of Consciousness, 6(4), 329-345.

113. * Thomas, E.A., Mijangos, J., Walker, D., Reimers, C., Beck, A., Hansen, P., & Garland, E.L. (2019). Mindfulness-Oriented Recovery Enhancement restructures reward processing and promotes interoceptive awareness in overweight cancer survivors: Mechanistic results from a stage 1 RCT. Integrative Cancer Therapies, 18, 1534735419855138.

114. Garland, E. L., Reese, S.E., Bedford, C.E., & Baker, A.K. (2019). Adverse childhood experiences predict autonomic indices of emotion dysregulation and negative emotional cue-elicited craving among female opioid-treated chronic pain patients. Development and Psychopathology, 31, 1101-1110.

115. Garland, E.L., Bryan, M.A., Hanley, A.W., & Howard, M.O. (2019). Neurocognitive mechanisms of mindfulness-based interventions for addiction. In Verdejo-Garcia, A. (ed.), Cognition and Addiction. Elsevier.

116. * Hanley, A.W., & Garland, E.L. (2019). Mindfulness training disrupts Pavlovian conditioning. Physiology & Behavior, 204, 151-154.

117. * Hanley, A.W., Gonzalez-Pons, K.M., & Garland, E.L. (2019). Traumatically mindful: Investigating the link between exposure to potentially traumatizing events and greater dispositional mindfulness. International Journal of Existential Positive Psychology, 8(1), 1-11.

118. * Garland, E.L. (2019). Standing on the shoulders of giants: Matthew O. Howard as a mentor and his influence on the study of mindfulness as a treatment for addiction. Journal of the Society for Social Work and Research, 93, 7-12.

119. McConnell, P.A., Garland, E.L., Zubieta, J.-K., Neman-Norlund, R., Powers, S., Froeliger, B. (2019). Frontostriatal resting-state functional connectivity is associated with negative affect among opioid using pain patients. Addiction Biology. 2019, 1-11.

120. * Garland E.L., Bryan, M.A., Priddy, S.E., Riquino, M.R., Froeliger, B., & Howard, M.O. (2019). Effects of Mindfulness-Oriented Recovery Enhancement versus social support on negative affective interference during inhibitory control among opioid-treated chronic pain patients: A pilot mechanistic study. Annals of Behavioral Medicine, 53(10), 865-876.

121. Bettman, J.E., Scheinfeld, D., Prince, K., & Garland, E.L. (2019). Changes in psychiatric symptoms and psychological processes among veterans participating in a therapeutic adventure program. Psychological Services, 16(4), 525-534.

122. Geschwind, N., Martinmäki,, S., & Garland, E.L. (2019). Facilitation of positive emotions through mindfulness-based therapy. In Gruber, J. (ed.), Positive Emotions and Psychopathology. Oxford University Press.

123. * Garland, E.L., Bryan, C.J., Kreighbaum, L., Nakamura, Y., Howard, M.O., & Froeliger, B.E. (2018). Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the Cue-Primed Reactivity Task. Drug and Alcohol Dependence, 187, 13-21.

124. * Garland, E.L., & Howard, M.O. (2018). Mindfulness-based treatment of addiction: Current state of the field and envisioning the next wave of research. Addiction Science and Clinical Practice, 13(1), 1-14.

125. * Baker, A.K., & Garland, E.L. (2018). Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients. Experimental and Clinical Psychopharmacology, 27(1), 55-63.

126. McClintock, A., McCarrick, S., Garland, E.L., Zeidan, F., & Zgierska, A. (2018). Brief mindfulness-based interventions for acute and chronic pain: A systematic review. Journal of Alternative and Complementary Medicine, 25(3), 265-278.

127. * Hanley, A.W., Nakamura, Y., & Garland, E.L. (2018). The Nondual Awareness Dimensional Assessment (NADA): New tools to assess nondual traits and states of consciousness occurring within and beyond the context of meditation. Psychological Assessment, 30(12).

128. * Priddy, S.E., Howard, M.O., Hanley, A.W., Riquino, M.R., Friberg-Felsted, K., Garland, E.L. (2018). Mindfulness meditation in the treatment of substance use disorders and preventing future relapse: Neurocognitive mechanisms and clinical implications. Substance Abuse and Rehabilitation, 2018(9), 103-114.

129. * Riquino, M.R., Priddy, S.E., Howard, M.O., & Garland, E.L. (2018). Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients. Borderline Personality Disorder and Emotion Dysregulation, 5, 1-9.

130. Brown, S.M., Bender, K.A., Bellamy, J., Garland E.L., Dmitrieva, J., Jenson, J. (2021). A pilot randomized trial of a mindfulness-informed intervention for child welfare-involved families. Mindfulness, 12, 420-435. 

131. * Garland, E.L., Hanley, A.W., Bedford, C., Zubieta, J.-K., Howard, M.O., Nakamura, Y., Donaldson, G., & Froeliger, B. (2018). Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse. Journal of Addictive Diseases, 37(1-2), 14-22.

132. * Priddy, S.E., Hanley, A.W., Riquino, M.R., Platt, K., Baker, A.K., & Garland, E.L. (2018). Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms. Drug and Alcohol Dependence, 188, 86-93.

133. * De Vibe, M., Solhaug, I., Rosenvinge, J. H., Reidar, T., Hanley, A. W., & Garland, E. (2018). Long-term effect of a mindfulness-based intervention on mindfulness, coping and well-being in medical and psychology students; results from a randomized controlled trial. PLOS One. 13(4), e0196053.

134. * Garland, E.L., Baker, A.K., Larsen, P., Riquino, M.R., Priddy, S.E., Thomas, E.A., Hanley, A.W., Galbraith, P., Wanner, N., & Nakamura, Y. (2017). Randomized controlled trial of brief mindfulness training and hypnotic suggestion for acute pain relief in the hospital setting. Journal of General Internal Medicine, 32(10), 1106-1113.

135. * Garland, E.L., Hanley, A.W., Goldin, P.R., & Gross, J.G. (2017). Testing the Mindfulness-to-Meaning Theory: Evidence for mindful positive emotion regulation from a reanalysis of longitudinal data. PLOS One, 12(12), e0187727.

136. * Garland, E.L. & Howard, M.O. (2018). Enhancing natural reward responsiveness among opioid users predicts relief from chronic pain: An analysis of EEG data from a trial of Mindfulness-Oriented Recovery Enhancement. Journal of the Society for Social Work and Research, 9(2), 2334-2315. 

137. Li, W., Garland, E.L., & Howard, M.O. (2018). Therapeutic mechanisms of Mindfulness-Oriented Recovery Enhancement for internet gaming disorder: Reducing craving and addictive behavior by targeting cognitive processes. Journal of Addictive Diseases, 37(1-2), 5-13. 

138. * Garland, E.L., Bell, S., Atchley, R., & Froeliger, B. (2018). Emotion dysregulation in addiction. In Beachaine, T. (ed.), Oxford Handbook of Emotion Dysregulation, Oxford University Press.

139. * Hanley, A.W., Baker, A.K., Hanley, R., & Garland, E.L. (2018). The self taking shape: Mapping the self with multidimensional scaling. Personality and Individual Differences, 126, 25-32.

140. * Garland, E.L., Howard, M.O., Zubieta, J., & Froeliger, B. (2017). Restructuring hedonic dysregulation in chronic pain and prescription opioid misuse: Effects of Mindfulness-Oriented Recovery Enhancement on responsiveness to drug cues and natural rewards. Psychotherapy and Psychosomatics, 86(2), 111-112.

141. * Garland, E.L., Hanley, A.W., Baker. A.K., & Howard, M.O. (2017). Biobehavioral mechanisms of mindfulness as a treatment for chronic stress: An RDoC perspective. Chronic Stress. 1, 2470547017711912.

142. * Garland, E.L., Bryan, C.J., Nakamura, Y., Froeliger, B., & Howard, M.O. (2017). Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse. Psychopharmacology, 234(4), 621-629.

143. * Garland, E.L., Baker, A.K., & Howard, M.O. (2017). Mindfulness-Oriented Recovery Enhancement reduces opioid attentional bias among prescription opioid-treated chronic pain patients. Journal of the Society for Social Work and Research, 8(4), 493-509.

144. * Hanley, A.W., Baker, A.K., & Garland, E.L. (2017). Self-interest may not be entirely in the interest of the self: Association between selflessness, dispositional mindfulness and psychological well-being. Personality and Individual Differences, 117, 166-171.

145. * Hanley, A.W., Mehling, W., & Garland, E.L. (2017). Holding the body in mind: Interoceptive awareness, dispositional mindfulness, and psychological well-being. Journal of Psychosomatic Research, 99, 13-20.

146. * Garland, E.L., Bryan, C.J., Finan, P., Thomas, E.A., Priddy, S.E., Riquino, M., & Howard, M.O. (2017). Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients. Drug and Alcohol Dependence, 173, S65-S72.

147. * Garland, E.L., Baker, A.K., Riquino, M.R., & Priddy, S.E. (2017). Mindfulness-Oriented Recovery Enhancement: A review of its theoretical underpinnings, clinical application, and biobehavioral mechanisms. In Ivtzan, I. (ed.), Handbook of Mindfulness-Based Programs: Every Established Intervention, from Medicine to Education. Routledge Press.

148. * Hanley, A.W., Baker, A.K., & Garland, E.L. (2017). The mindful personality II: Exploring the metatraits from a cybernetic perspective. Mindfulness, 9(3), 972-979.

149. * Hanley, A.W., & Garland, E.L. (2017). The mindful personality: A meta-analysis from a cybernetic perspective. Mindfulness, 8(6), 1456-1470.

150. Li, W., Garland, E.L., McGovern, P., O’Brien, J.E., Tronnier, C., & Howard, M.O. (2017). Mindfulness-Oriented Recovery Enhancement for internet gaming disorder in U.S. adults: A stage 1 randomized controlled trial. Psychology of Addictive Behaviors, 31, 393-402.

151. Froeliger, B., Mathew, A., McConnell, P., Eichberg, C., Saladin, M.E., Carpenter, M.J., & Garland, E.L. (2017). Restructuring reward mechanisms in nicotine addiction: A pilot fMRI study of Mindfulness-Oriented Recovery Enhancement for cigarette smokers. Evidence-Based Complementary and Alternative Medicine, 7018014. 

152. Li, W. Howard, M. O., Garland, E. L., McGovern, P., & Lazar, M. (2017). Mindfulness treatment for substance misuse: A systematic and meta-analysis. Journal of Substance Abuse Treatment, 75, 62-96.

153. Baucom, R.W., Georgiou, P., Bryan, C.J., Garland, E.L., Leifker, F., May, A., Wong, A., & Narayanan, S.S. (2017). The promise and the challenge of technology-facilitated methods for assessing behavioral and cognitive markers of risk for suicide among U.S. Army National Guard Personnel. International Journal of Environmental Research and Public Health, 14(4), 361

154. Li, W., Garland, E. L., O’Brien, J.E., Tronnier, C., McGovern, P., Howard, M. O. (2017). Mindfulness-Oriented Recovery Enhancement for video game addiction in emerging adults: Preliminary findings from case reports. International Journal of Mental Health and Addiction. 16, 928-945.

155. * Garland, E.L., Riquino, M.R., Priddy, S.E., & Bryan, C.J. (2017). Suicidal ideation is associated with individual differences in prescription opioid craving and cue-reactivity among chronic pain patients. Journal of Addictive Diseases, 36(1), 23-29.

156. Finan, P.H., Quartana, P.J., Remeniuk, B., Garland, E.L., Rhudy, J., Hand, M., Irwin, M.J., & Smith, M.T. (2017). Partial sleep deprivation attenuates the positive affective system: Effects across multiple measurement modalities. Sleep, 40(1), zsw017.

157. Badran, B.W., Austelle, C.W., Smith, N.R., Glusman, C.E., Froeliger, B., Garland, E.L., Borckardt, J.J., George, M.S., & Short, E.B. (2017). A double-blind study exploring the use of transcranial direct stimulation to potentially enhance mindfulness meditation (E-meditation). Brain Stimulation, 10(1), 152-154. 

158. Hanley, A.W., Garland, E.L., & Tedeschi, R.G. (2017). Relating dispositional mindfulness, contemplative practice and positive reappraisal with posttraumatic cognitive coping, stress and growth. Psychological Trauma: Theory, Research, Practice, and Policy, 9(5), 526-536.

159. * Thomas, E.A., & Garland, E.L. (2017). Mindfulness is associated with increased hedonic capacity among chronic pain patients receiving extended opioid pharmacotherapy. Clinical Journal of Pain, 33(2), 166-173.

160. * Garland, E.L., Kiken, L., Gaylord, S., Faurot, K., & Palsson, O. (2017). Upward spirals of mindfulness and reappraisal: Testing the Mindfulness-to-Meaning Theory with autoregressive latent trajectory modeling. Cognitive Therapy and Research, 41(3), 381-392

161. * Garland, E.L. (2016). Targeting hedonic dysregulation with Mindfulness-Oriented Recovery Enhancement: Restructuring reward mechanisms in addiction, stress, and pain. Annals of the New York Academy of Sciences, 1373, 25-37.

162. * Hanley, A.W. & Garland, E.L. (2016). Clarity of mind: Structural equation modeling of associations between dispositional mindfulness, self-concept clarity and psychological well-being. Personality and Individual Differences, 106, 334-339. 

163. Bryan, C.J., Garland, E.L., & Rudd, M.D. (2016). From impulse to action: Alcohol consumption and the transition from suicidal thought to behavior among active duty military personnel. General Hospital Psychiatry, 41, 13-19.

164. * Garland, E.L., Howard, M.O., Priddy, S.E., McConnell, P.A., Riquino, M.R., & Froeliger, B.E. (2016). Mindfulness training applied to addiction therapy: Insights into the neural mechanisms of positive behavioral change. Neuroscience and Neuroeconomics, 2016(5), 55-63.

165. * Garland, E.L., Roberts-Lewis, A., Tronnier, C., Kelley, K., & Graves, R. (2016). Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial. Behaviour Research and Therapy, 77, 7-16.

166. * Garland, E.L., Thielking, P., Thomas, E.A., Coombs, M., White, S., Lombardi, J., & Beck, A. (2016). Linking dispositional mindfulness and positive psychological processes in cancer survivorship: A multivariate path analytic test of the Mindfulness-to-Meaning Theory. Psycho-Oncology. 26(5), 686-692.

167. * Garland, E.L., Farb, N.A., Goldin, P.R., & Fredrickson, B.L. (2015). The Mindfulness-to-Meaning Theory: Extensions, applications, and challenges at the attention-appraisal-emotion interface. Psychological Inquiry, 26(4), 377-387.

168. * Garland, E.L., Brown, S., & Howard, M.O. (2016). Thought suppression as a mediator of the association between depressed mood and prescription opioid craving among chronic pain patients. Journal of Behavioral Medicine, 39(1), 128-138.

169. * Li, M.J., Black, D.S., & Garland, E.L. (2016). The Applied Mindfulness Process Scale: A process measure for evaluating mindfulness-based interventions. Personality and Individual Differences, 93, 6-15.

170. * Kelly, A.R., & Garland, E.L. (2016). Trauma-informed Mindfulness-Based Stress reduction for female survivors of interpersonal violence: Results from a Stage I RCT. Journal of Clinical Psychology, 72(4), 311-328.

171. * Garland, E.L., Farb, N.A.S., Goldin, P., & Fredrickson, B.L. (2015). Mindfulness broadens awareness and builds eudaimonic meaning: A process model of mindful positive emotion regulation. Psychological Inquiry, 26(4), 293-314.

172. * Garland, E.L., Froeliger, B., & Howard, M.O. (2015). Allostatic dysregulation of natural reward processing in prescription opioid misuse: Autonomic and attentional evidence. Biological Psychology, 105, 124-129.

173. Hanley, A.W., Canto, A.I., Palejwala, M., & Garland, E.L. (2015). A failure in mind: Dispositional mindfulness and positive reappraisal as predictors of academic self-efficacy following failure. Personality and Individual Differences, 86, 332-337.

174. * Garland, E.L., Brown, S., & Howard, M.O. (2015). Traumatic experiences and reduced alcohol self-efficacy among alcohol dependent inpatients: Attentional and autonomic mediators. Bulletin of Clinical Psychopharmacology, 25(4), 355-364.

175. * Garland, E.L., & Howard, M.O. (2014). Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients. Drug and Alcohol Dependence, 144, 283-287.

176. * Garland, E.L., Geschwind, N., Peeters, F., & Wichers, M. (2015). Mindfulness training promotes upward spirals of positive affect and cognition: Multilevel and autoregressive latent trajectory modeling analyses. Frontiers in Psychology: Emotion Science, 6, 15.

177. Howard, M.O., Bowen, S.E., & Garland, E.L. (2015).  Inhalant-related disorders.  In B.J. Sadock, V.A. Sadock, & Ruiz, P. (Eds), Comprehensive Textbook of Psychiatry, 10th Edition.  Lippincott Williams & Wilkins, Baltimore, MD.

178. Bowen, S.E, Howard, M.O., & Garland, E.L. (2015).  Inhalant use disorders in the United States.  In V. Preedy (Ed.), The neuropathology of drug addictions and substance misuse.  Academic Press, 6, 18-31.

179. Howard, M.O., Bowen, S.E., & Garland, E.L. (2015).  Inhalant use disorder.  In A.E. Wenzel (Ed.), Sage encyclopedia of abnormal and clinical psychology.  New York: Sage Publications.

180. * Garland, E.L., & Thomas, E.A. (2015). Neuroscience, resilience, and the embodiment of “mental” disorder. In Probst, B. (ed.), Critical Thinking in Clinical Diagnosis and Assessment. New York: Springer, 17(3), 94.

181. Howard, M.O., & Garland, E.L. (2015). Social Work: 2044. Journal of the Society for Social Work and Research, 6(2), 173-200.

182. * Garland, E.L., Froeliger, B.E., & Howard, M.O. (2015). Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: Exploratory ERP findings from a pilot RCT. Journal of Behavioral Medicine, 38(2), 327-336.

183. Kiken, L.G., Garland, E.L., Palsson, O., Faurot, K., Bluth, K., & Gaylord, S.A. (2015). From a state to a trait: Trajectories of state mindfulness in meditation during intervention predict changes in trait mindfulness. Personality and Individual Differences, 81, 41-46.

184. * Garland, E.L., Hanley, A., Thomas, E.A. Knoll, P., & Ferraro, J. (2015). Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids. Journal of Addiction Medicine, 9, 61-67.

185. * Garland, E.L., Beck, A., Lipschitz, D., & Nakamura, Y. (2015). Dispositional mindfulness predicts attenuated waking salivary cortisol levels in cancer survivors: A latent growth curve analysis. Journal of Cancer Survivorship, 9(2), 215-222.

186. McConnell, P., Froeliger, B., Garland, E.L., Ives, J.C., & Sforzo, G. (2014). Auditory driving of the autonomic nervous system: Listening to theta-frequency binaural beats post-exercise increases parasympathetic activation and sympathetic withdrawal. Frontiers in Psychology, 5, 1248.

187. * Hanley, A., Warner, A., Canto, A., & Garland, E.L. (2014). Washing the dishes to wash the dishes: Brief instruction in an informal mindfulness practice. Mindfulness, 6(5), 1095-1103.

188. * Garland, E.L., Froeliger, B., & Howard, M.O. (2014). Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity. Psychopharmacology, 231(16), 3229-3238.

189. * Garland, E.L., Manusov, E.G., Froeliger, B., Kelly, A., Williams, J., & Howard, M.O. (2014). Mindfulness-Oriented Recovery Enhancement for chronic pain and prescription opioid misuse: Results from an early stage randomized controlled trial. Journal of Consulting and Clinical Psychology, 82(3), 448-459. 

190. * Garland, E.L., Froeliger, B., & Howard, M.O. (2014). Mindfulness training targets neurocognitive mechanisms of addiction at the attention-appraisal-emotion interface. Frontiers in Psychiatry, 4, 173. 

191. * Garland, E.L., Thomas, E.A., & Howard, M.O. (2014). Mindfulness-Oriented Recovery Enhancement ameliorates the impact of pain on self-reported psychological and physical function among opioid-using chronic pain patients. Journal of Pain and Symptom Management, 48(6), 1091-1099.

192. * Garland, E.L. (2014). Treating chronic pain: The need for non-opioid options. Expert Review of Clinical Pharmacology, 7(5), 545-550.

193. * Garland, E.L. (2014). Dismantling mindfulness-based cognitive therapy for recurrent depression implicates lack of differential efficacy for mindfulness training. Evidence-Based Mental Health, 17(3), 94.

194. Finan, P., & Garland, E.L. (2015). The role of positive affect in chronic pain and its treatment. Clinical Journal of Pain, 31(2), 177-187.

195. * Hanley, A.W., Warner, A., & Garland, E.L. (2015). Associations between mindfulness, psychological well-being, and subjective well-being with respect to contemplative practice. Journal of Happiness Studies, 16, 1423-1426.

196. * Garland, E.L. (2014). Disrupting the downward spiral of chronic pain and opioid addiction with Mindfulness-Oriented Recovery Enhancement: A review of clinical outcomes and neurocognitive targets. Journal of Pain and Palliative Care Pharmacotherapy, 28(2), 122-129.

197. * Garland, E.L., Froeliger, B., Zeidan, F., Partin, K., & Howard, M.O. (2013). The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways. Neuroscience & Biobehavioral Reviews, 37, 2597-2607

198. * Hanley, A.W., & Garland, E.L. (2014). Dispositional mindfulness co-varies with self-reported positive reappraisal. Personality & Individual Differences, 66, 146-152.

199. * Hanley, A.W., Peterson, G.W., Canto, A.I., & Garland, E.L. (2015). The relationship between mindfulness and posttraumatic growth with respect to contemplative practice engagement. Mindfulness, 6, 654-662.

200. * Garland, E.L., & Hanley, A.W., Farb, N.A., & Froeliger, B. (2015). State mindfulness during meditation predicts enhanced cognitive reappraisal. Mindfulness, 6(2), 234-242.

201. * Garland, E.L., & Howard, M.O. (2013). Mindfulness-Oriented Recovery Enhancement reduces pain attentional bias in chronic pain patients. Psychotherapy and Psychosomatics, 82, 311-318.

202. * Garland, E.L., & Black, D.S. (2014). Mindfulness for chronic pain and prescription opioid misuse: Novel mechanisms and unresolved issues. Substance Use and Misuse, 49(5), 608-611.

203. Howard, M.O., Garland, E.L., Sharp, C.W., Rosenberg, N., & Beauvais, F. (2013). Substance abuse: Inhalant-related disorders. In A. Tasman, J. Kay, J. Lieberman, M. First, & M. Maj (Eds.) Psychiatry (4th ed.). New York: John Wiley & Sons.

204. Li, W., Garland, E.L., & Howard, M.O. (2014). Family correlates of internet addiction in Chinese adolescents and young adults: A review of English- and Chinese-language studies. Computers in Human Behavior, 31, 393-411.

205. Hanley, A., Garland, E.L., Canto, A., Warner, A., & Hanley, R. (2013). Mind the extremes: Dispositional mindfulness and bias in self-theories. Mindfulness, 6, 202-207.

206. * Garland, E.L., & Howard, M.O. (2014). A transdiagnostic perspective on cognitive, affective, and neurobiological processes underlying human suffering. Research on Social Work Practice, 24(1), 142-151.

207. * Garland, E.L., Froeliger, B.E., Passik, S.D., & Howard, M.O. (2013). Attentional bias for prescription opioid cues among opioid-dependent chronic pain patients. Journal of Behavioral Medicine, 36(6), 611-620. 

208. Hanley, A., Garland, E.L., & Black, D. (2014). Use of mindful reappraisal coping among meditation practitioners. Journal of Clinical Psychology, 70(3), 294-301.

209. * Garland, E.L., Roberts-Lewis, A., Kelley, K., Tronnier, C., & Hanley, A. (2014). Cognitive and affective mechanisms linking trait mindfulness to craving among individuals in addiction recovery. Substance Use and Misuse, 49(5), 525-535.

210. * Kelly, A., & Garland, E.L. (2014). Treatment of depression and coping with chronic pain through Mindfulness-Oriented Recovery Enhancement. In C.W. LeCrory (ed.), Case Studies in Social Work Practice. Wiley: New York.

211. Coeytaux, R., & Garland, E.L. (2013). Acupuncture for the treatment or management of chronic pain. North Carolina Medical Journal, 74(3), 221-225.

212. Froeliger, B.E., Garland, E.L., & McClernon, F.J. (2013). Yoga meditation practitioners exhibit greater gray matter volume and fewer reported cognitive failures: Results of a preliminary voxel-based morphometric analysis. Evidence-Based Complementary and Alternative Medicine. Article ID 821307.

213. * Garland, E.L., & Froeliger, B.E. (2014). Mindfulness training targets addiction at the attention-emotion interface: A neurocognitive framework. In E. Langer, A. Le, & C. Ngoumen (eds.), Handbook of Mindfulness, Wiley-Blackwell.

214. Greeson, J.M., Garland, E.L., & Black, D.S. (2014). Mindfulness: A transtherapeutic approach for transdiagnostic mental processes. In E. Langer, A. Le, & C. Ngoumen (eds.), Handbook of Mindfulness, Wiley-Blackwell.

215. Garland, E.L., Pettus-Davis, C., & Howard, M.O. (2013). Self-medication among traumatized youth: Structural equation modeling of pathways between trauma history, substance misuse, and psychological distress. Journal of Behavioral Medicine, 36(2), 175-185.

216. * Garland, E.L., Franken, I.H., Sheetz, J.J., & Howard, M.O. (2012). Alcohol attentional bias is associated with autonomic indices of stress-primed alcohol cue-reactivity in alcohol dependent patients. Experimental and Clinical Psychopharmacology, 20, 225-235.

217. Garland, E.L., & Howard, M.O. (2012). Volatile substance misuse: Clinical considerations, neuropsychopharmacology, and potential role of pharmacotherapy in management. CNS Drugs, 26, 927-935.

218. Howard, M.O., & Garland, E.L. (2012). Volatile substance misuse: A research agenda. American Journal of Drug and Alcohol Abuse, 39(1), 3-7. 

219. Howard, M.O., & Garland, E.L. (2012). Adolescent volatile substance misuse: Atypical agents, perceived intoxication, and patterns of use. Clinical Toxicology, 1(10), 1-3.

220. Froeliger, B.E., Modlin, L., Kozink, R., Wang, L., Garland, E.L., Addicott, M.A. & McClernon, F.J. (2013). Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. Psychiatry Research – Neuroimaging, 211(1), 57-63.

221. * Garland, E.L., & Roberts-Lewis, A. (2013). Differential roles of thought suppression and dispositional mindfulness in posttraumatic stress symptoms and craving. Addictive Behaviors, 38, 1555-1562.

222. * Garland, E.L., Williams, J., Gale, H., Kelly, A., & Howard, M.O. (2013). Targeting transdiagnostic processes in clinical practice through mindfulness: Cognitive, affective, and neurobiological perspectives. In H. Matto (ed.), Social Work and Neuroscience, Springer.

223. * Garland, E.L., & Fredrickson, B.A. (2013). Mindfulness broadens awareness and builds meaning at the attention-emotion interface. In T.B. Kashdan & J. Ciarrochi, J. (eds.), Linking Acceptance and Commitment Therapy and Positive Psychology: A Practitioner’s Guide to a Unifying Framework, pp. 30 – 67. New Harbinger Publications, Inc.: Oakland, CA.

224. * Garland, E.L., Schwarz, N., Kelly, A., Whitt, A., & Howard, M.O. (2012). Mindfulness-Oriented Recovery Enhancement for alcohol dependence: Therapeutic mechanisms and intervention acceptability. Journal of Social Work Practice in the Addictions, 12, 242-263.

225. Froeliger, B.E., Garland, E.L., Modin, L., & McClernon, F.J. (2012). Neurocognitive correlates of yoga meditation practice on emotion and cognition: A pilot study. Frontiers in Neuroscience, 6(48), 1-11.

226. Whitt, A., Garland, E.L., & Howard, M.O. (2012). Helium inhalation in adolescents: Associations with substance misuse. Journal of Psychoactive Drugs, 44(5), 365-371.

227. * Garland, E.L., Franken, I.H., & Howard, M.O. (2012). Cue-elicited heart rate variability and attentional bias predict alcohol relapse following treatment. Psychopharmacology, 222, 17-26.

228. * Garland, E.L. (2012). Pain processing in the human nervous system: A selective review of nociceptive and biobehavioral pathways. Primary Care: Clinics in Office Practice, 39(3), 561-571.

229. Gaylord, S.A., Palsson, O., Garland, E.L., Faurot, K., Mann, D.J., Whitehead, W. (2012). Response to “Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial.” Gastroenterology, 106(9), 1678-1688.

230. Froeliger, B.E., Garland, E.L., Kozink, R.V., Modlin, L., Chen, N., McClernon, F.J., Greeson, J.M., & Sobin, P. (2012). Meditation-state resting functional connectivity: Strengthening of the dorsal attention network and beyond. Evidence-Based Complementary and Alternative Medicine. Article ID 680407.

231. * Garland, E.L., Carter, K., Ropes, K., & Howard, M.O. (2012). Thought suppression, impaired regulation of alcohol urges, and Addiction-Stroop predict affect-modulated cue-reactivity among alcohol dependent adults. Biological Psychology, 89(1), 87-93.

232. * Garland, E.L., Gaylord, S.A., Palsson, O., Faurot, K., Mann, J.D., & Whitehead, B. (2012). Therapeutic mechanisms of a mindfulness-based treatment for irritable bowel syndrome: Effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. Journal of Behavioral Medicine, 35(6), 591-602. 

233. Howard, M.O., & Garland, E.L. (2012). Our best schools of social work: How good are they? Social Work Research, 35(4), 195-201.

234. * Garland, E.L. (2011). Trait mindfulness predicts attentional and autonomic regulation of alcohol cue-reactivity. Journal of Psychophysiology, 25(4), 180-189.

235. * Garland, E.L., & Thyer, B. (2012). Cognitive-behavior therapy in social work practice. In S. Webb & M. Grey (eds.), Social Work Theories and Methods, 2nd ed . Sage.

236. Howard, M.O., Garland, E.L., & Whitt, A. (2012). Contemporary and historical perspectives. In B. Perron & M. Vaughn (eds.), Social Work Practice in the Addictions. Springer.

237. * Garland, E.L., Boettiger, C.A., Gaylord, S., West Chanon, V., & Howard, M.O. (2012). Mindfulness is inversely associated with alcohol attentional bias among recovering alcohol-dependent adults. Cognitive Therapy and Research, 36, 441-450. 

238. Gaylord, S.A., Palsson, O., Garland, E.L., Faurot, K., Coble, R., Frey, W., Mann, D.J., Whitehead, W. (2011). Mindfulness training reduces the severity of irritable bowel syndrome in women: Results of a randomized controlled trial. American Journal of Gastroenterology, 106(9), 1678-1688.

239. * Garland, E.L. (2013). Mindfulness research in social work: Conceptual and methodological recommendations. Social Work Research, 37(4), 439-448.

240. Garland, E.L., Carter, K., Howard, M.O. (2011). Prevalence, correlates, and characteristics of gasoline misuse among high-risk youth: Associations with self-medication, suicidal ideation, and antisociality. Bulletin of Clinical Psychopharmacology, 21(2), 105-113.

241. Huston, D., Garland, E.L., Farb, N. (2011). Mechanisms of mindfulness in communications training. Journal of Applied Communication Research, 39(4), 406-421.

242. * Garland, E.L., Boettiger, C.A., & Howard, M.O. (2011). Targeting cognitive-affective risk mechanisms in stress-precipitated alcohol dependence: An integrated, biopsychosocial model of allostasis, automaticity, and addiction. Medical Hypotheses, 76, 745-754.

243. * Garland, E.L., & Howard, M.O. (2011). Adverse consequences of acute inhalant intoxication. Experimental and Clinical Psychopharmacology, 19(2), 134-144.

244. * Garland, E.L., Gaylord, S.A., & Fredrickson, B.L. (2011). Positive reappraisal coping mediates the stress-reductive effect of mindfulness: An upward spiral process. Mindfulness, 2(1), 59-67.

245. * Garland, E.L. & Howard, M.O. (2011). Desistance motivations among adolescent inhalant users: Latent class and profile analyses. Addiction Research and Theory, 19(3), 189-198.

246. Garland, E.L., Howard, M.O., Vaughn, M.G., & Perron, B.E. (2011). Volatile substance misuse in the United States. Substance Use and Misuse, 46, 8-20.

247. * Garland, E.L., Gaylord, S.A., Boettiger, C.A., & Howard, M.O. (2010). Mindfulness training modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: Results from a randomized controlled pilot trial. Journal of Psychoactive Drugs, 42(2), 177-192.

248. * Garland, E.L., Fredrickson, B.L., Kring, A.M., Johnson, D.P., Meyer, P.S., & Penn, D.L. (2010). Upward spirals of positive emotions counter downward spirals of negativity: Insights from the broaden-and-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathology. Clinical Psychology Review, 30, 849-864.

249. * Garland, E.L. & Howard, M.O. (2010). Phenomenology of adolescent inhalant intoxication. Experimental and Clinical Psychopharmacology, 18(6), 498-509.

250. * Garland, E.L., & Howard, M.O. (2010). Inhalational abuse of computer duster spray among adolescents: An emerging public health threat? American Journal of Drug and Alcohol Abuse, 36(6), 320-324.

251. Howard, M.O., Bowen, S., Garland, E.L., Perron, B.E., & Vaughn, M.G. (2011). Inhalant use and inhalant use disorders in the United States. Addiction Science & Clinical Practice, 6, 18-31.

252. Howard, M.O., Garland, E.L., Perron, B.E., & Vaughn, M.G. (2010).  Inhalant abuse.  In J.R. Ripple, M.D. (Ed.), Encyclopedia of Lifestyle Medicine and Health.  Sage Press.

253. Howard, M.O., Perron, B.E., Sacco, P., Ilgen, M., Vaughn, M.G., Garland, E.L., & Freedenthal, S. (2010). Suicide ideation and attempts among inhalant users: Results from a national survey. Suicide and Life Threatening Behaviors, 40(3), 276-286.

254. Howard, M.O., Perron, B.E., Vaughn, M.G., Bender, K.A., & Garland, E.L. (2010). Inhalant use, inhalant use disorders and antisocial behavior: Findings from the National Epidemiologic Survey of Alcohol and Related Disorders (NESARC). Journal of Studies on Alcohol and Drugs, 71, 201-209.

255. * Garland, E.L. & Howard, M.O. (2009). Neuroplasticity, psychosocial genomics, and the biopsychosocial paradigm in the 21st century. Health & Social Work, 34(3), 191-200.

256. * Garland, E.L., Howard, M.O., & Perron, B.E. (2009). Nitrous oxide inhalation among adolescents: Prevalence, correlates, and co-occurrence with volatile solvent inhalation. Journal of Psychoactive Drugs, 41(4), 337-347.

257. * Garland, E.L. & Fredrickson, B. (2009). Application of the broaden-and-build theory of positive emotions to intimate partner violence. In P. Lehmann & C. Simmons (eds.), Strengths-based batterer intervention: A new paradigm in ending family violence. (pp. 189-216). New York: Springer. 

258. * Garland, E.L. & Gaylord, S. (2009). Envisioning a future contemplative science of mindfulness: Fruitful methods and new content for the next wave of research. Complementary Health Practice Review, 14(1), 3-9.

259. * Garland, E.L., Gaylord, S., & Park, J. (2009). The role of mindfulness in positive reappraisal. Explore, 5(1), 37-44.

260. Pettus-Davis, C., & Garland, E.L. (2009). Ban juvenile transfer to adult court in homicide cases: Brain development and the need for a blended sentence approach. In T. Clear, N. Frost & J. Freilich (eds.) Contemporary issues in criminal justice policy. Policy proposals from the American Society of Criminology conference.

261. Gaylord, S., Whitehead, W., Coble, R., Faurot, K., Palsson, O., Garland, E., Frey, W., & Mann, J.D. (2009). Mindfulness for irritable bowel syndrome: Protocol development for a controlled clinical trial. BMC Complementary and Alternative Medicine, 9(24).
     
262. * Garland, E.L. (2007). The meaning of mindfulness: A second-order cybernetics of stress, metacognition, and coping. Complementary Health Practice Review, 12(1), 15-30.

EXTERNAL REVIEWS OF PRIMARY SCHOLARLY WORK

Selected Out of >160 Independent Reviews or News Reports:

Berridge, K.C. (2024). Drug cues trigger corticolimbic hyperreactivity in heroin users. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20231000

Congressionally Directed Medical Research Program (CDMRP). (2024). “CDMRP Funds Research to Reduce Opioid Use in Veterans and Service Members with Chronic Pain.” https://cdmrp.health.mil/prmrp/research_highlights/Opioid_Misuse_Prevention.aspx

Kileen, T.K. & Brewerton, T.D. (2024). MORE Is less pain and less opioid misuse: A mindful remedy. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20231001

February 2024 American Journal of Psychiatry Editor Spotlight for Garland et al. 2024 “Mindfulness-Oriented Recovery Enhancement for veterans and military personnel on long-term opioid therapy for chronic pain: A randomized clinical trial” https://www.youtube.com/watch?v=WfpusMd85yY

February 2024 American Journal of Psychiatry Editor Spotlight for Huang et al. 2024 “Association of cortico-striatal engagement during cue-reactivity, reappraisal, and savoring of drug and non-drug stimuli with craving in heroin addiction” https://www.youtube.com/watch?v=WfpusMd85yY

Parvaz, M. & Gross, J. (2022). Emotion dysregulation and opioid misuse. Biological Psychiatry, 91(12), 1005-1007.

Slomski, A. (2022). Mindfulness-based therapy reduces chronic pain and opioid misuse. JAMA, 327(17):1641.

Martin, K. (2022). Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain. Eric L. Garland, Social Work, 67(3) 301–302. https://doi.org/10.1093/sw/swac024

Inverse.com “Meditation changes how your neurons move” 10/2022

Robinson, A. (2022). Ann Robinson’s Research Reviews for Garland et al. 2022 “Mindfulness-Oriented Recovery Enhancement versus supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: A randomized clinical trial”, BMJ, 2022;377:o960.

Psychology Today “Mindfulness therapy can reduce chronic pain and opioid misuse” 5/2022

TIME Magazine “How to get healthier dopamine highs” 5/2022

Medscape “Mindfulness intervention curbs opioid misuse, chronic pain” 5/2022

Science Daily “Mindfulness therapy reduces opioid misuse and chronic pain in primary care, according to new research” 5/2022

EurekaAlert! AAAS “Mindfulness therapy reduces opioid misuse and chronic pain in primary care, according to new research” 5/2022

New York Times “How psychologists can help treat chronic pain” 11/2021

Scientific American “The unexpected diversity of pain” 1/2020

National Public Radio (NPR) “Meditation reduced the opioid dose she needs to ease chronic pain by 75%” 11/2019

U.S. News and World Report “Meditation, mindfulness hold promise for pain treatment, curbing opioid use” 11/2019

AAAS “Mindfulness-based treatment may ease opioid addictions” 10/2019

Los Angeles Times “Opioid addiction can be overcome with mindfulness, study suggests” 10/2019

Herald Sun “Opioid addiction can be overcome with mindfulness, study suggests” 10/2019

The Sacramento Bee “Opioid addiction can be overcome with mindfulness, study suggests” 10/2019

Wall Street Journal “Wash the dishes and cleanse the mind” 9/2015

National Institute on Drug Abuse (NIDA) “Mindfulness training may reduce deficits in natural reward processing during chronic pain or drug addiction”  https://archives.nida.nih.gov/news-events/science-highlight/mindfulness-training-may-reduce-deficits-in-natural-reward-processing-during-chronic-pain-or-drug. 1/2015

The New Social Worker. Book Review: “Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain.”  https://www.socialworker.com/feature-articles/reviews-commentary/book-review-mindfulness-oriented-recovery-enhancement/ 4/2014

 MAJOR PROFESSIONAL PRESENTATIONS

1. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Neurophysiological Mechanisms of an Evidence-Based Integrative Therapy for Chronic Pain and Addiction. Grand Rounds, University of Vermont Department of Psychiatry. September 27, 2024
2. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Neurophysiological Mechanisms of an Evidence-Based Treatment for Pain, Emotional Distress, and Addiction. Grand Rounds, Center for Integrative and Complementary Medicine, Lausanne University Hospital, Lausanne, Switzerland, June 25, May 21, 2024.

3. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, Department of Psychiatry, Dartmouth Health, May 21, 2024.

4. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, Office of Correctional Medicine, Southern Illinois University, May 14, 2024.

5. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement Reduces Addictive Behavior by Evoking the Neurophysiological Signature of Self-Transcendence. Harvard Medical School, May 10, 2024.

6. Garland, E.L. (2024). KetaMORE: Ketamine-Assisted Psychotherapy Plus Mindfulness-Oriented Recovery Enhancement. Utah Psychedelic Science Initiative, Department of Psychiatry, University of Utah, May 7, 2024.

7. Garland, E.L. (2024). Outside the Box: How to Develop an Innovative Intervention Research Program. NIH PURPOSE Meeting, Washington, DC, May 3, 2024.

8. Zeidan, F. & Garland, E.L. (2024). Against the Grain: Advancing a Research Career When You Don’t Fit the Mold. NIH PURPOSE Meeting, Washington, DC, May 3, 2024.

9. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, Department of Psychiatry, University of Missouri, Columbia, MO, March 27, 2024.

10. Garland, E.L. (2024). Healing the Opioid Crisis with Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Addiction and Chronic Pain. Invited briefing, U.S. Congress, House of Representatives, Addiction Treatment and Recovery Caucus, March 20, 2024.

11. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement Builds Emotional Wellbeing By Restructuring Reward, Meaning, and Self. Invited keynote lecture, National Institutes of Health (NIH), Emotional Wellbeing Network Meeting, March 18, 2024.

12. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, University Hospitals, Case Western Reserve, February 27, 2024.

13. Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Neurophysiological Mechanisms of an Evidence-Based Treatment for Addiction and Chronic Pain. Grand Rounds, Laureate Institute for Brain Research (LIBR), Tulsa, OK, February 6, 2024.

14. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Mechanisms of an Evidence-Based Treatment for Opioid Misuse and Chronic Pain. Symposia at the American Academy of Addiction Psychiatry, Rancho Bernardo, CA, December 7, 2023.

15. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, Essentia Health, November 15, 2023.

16. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Neurophysiological Mechanisms of an Integrative Health Intervention for Chronic Pain and Addiction. Keynote lecture, Oregon Center for Complementary & Alternative Medicine in Neurological Disorders (ORCCAMIND), November 9, 2023.

17. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based, Neuroscience-Informed Therapy for Addiction, Stress, and Pain. Keynote lecture, Cape Cod Symposium for Addictive Disorders, Hyannis, MA, September 9, 2023.

18. Garland, E.L. (2023). Healing Addiction, Stress, and Pain with Mindfulness-Oriented Recovery Enhancement: A New, Evidence-Based, Neuroscience-Informed Treatment Approach. Keynote lecture, Addictions Research Update, Huntsman Mental Health Institute, June 12, 2023.

19. Garland, E.L., & Hanley, A.W. (2023). Healing Addiction, Stress, and Pain with Mindfulness-Oriented Recovery Enhancement: A New, Evidence-Based, Neuroscience-Informed Treatment Approach. RxSummit, Atlanta, GA, April 11, 2023.

20. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, University of Hawaii School of Medicine, March 28, 2023.

21. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, University of North Carolina at Chapel Hill School of Medicine, February 23, 2023.

22. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement Reduces Opioid Use by Evoking the Neurophysiological Signature of Self-Transcendence and Nonduality. International Symposium for Contemplative Research, San Diego, CA, February 4, 2023.

23. Garland, E.L. (2023). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, University of Utah Department of Psychiatry, February 1, 2023.

24. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement Targets Addiction by Restructuring Reward from Hedonic Pleasure to Self-Transcendent Meaning. Invited presentation to the NIH Behavioral and Social Sciences Research Festival, Office of Behavioral and Social Science Research (OBSSR), National Institutes of Health. December 8, 2022.

25. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, Northwestern University Department of Medicine, October 11, 2022.

26. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Grand Rounds, Cambridge Health Alliance, Boston, MA, October 6, 2022.

27. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder. National Institute for Allergies and Infectious Disease (NIAID), September 22, 2022.

28. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: A Group Visit Model for Addressing Chronic Pain, Opioid Misuse, and Opioid Use Disorder. Integrated Group Medical Visit Conference, September 16, 2022.

29. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain. Workshop for the Annual State of the Art of Addiction Medicine Conference of the California Society for Addiction Medicine, San Diego, CA, August 26, 2022.

30. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: An Innovative, Neuroscience-Based Treatment to Help Heal the Opioid Crisis. Plenary lecture, East Coast Symposium for Addictive Disorders, Baltimore, MD, August 19, 2022.

31. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: A New, Neuroscience-Based Treatment for Addiction and Pain. Plenary lecture, Kaiser Permanente Mental Health Conference, August 13, 2022.

32. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: A Neuroscience-Informed Treatment for Addiction and Pain. Plenary lecture, New Jersey Prevention Network Annual Addiction Conference, June 23, 2022.

33. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Intervention for Chronic Pain, Addictive Behavior, and Emotion Dysregulation. Invited presentation for the International Mindfulness Symposium, University of Fribourg, Switzerland, June 9, 2022.

34. Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of An Evidence-Based Therapy for Chronic Pain and Opioid Misuse. Invited Talk. Stanford Pain Relief Innovations Lab, Stanford School of Medicine, Stanford, CA, June 2, 2022. 

35. Garland, E.L. (2022). Digital Mindfulness Interventions: Friend or Foe? Symposium at International Congress of Integrative Medicine and Health, Phoenix, May 25, 2022.

36. Garland, E.L. (2022). Healing the Opioid Crisis with Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms from a Full-Scale RCT. International Congress of Integrative Medicine and Health, Phoenix, May 24, 2022.

37. Garland, E.L. (2022). Novel Mechanisms of Mindfulness-Based Interventions for Chronic Pain and Addiction: Self-Referential Processing and Reward. Symposium at International Congress of Integrative Medicine and Health, Phoenix, May 24, 2022.

38. Garland, E.L. (2022). Mindfulness-Oriented Recovery Enhancement for Women with Chronic Pain, Opioid Misuse, and Opioid Use Disorder: Biobehavioral Mechanisms and Clinical Outcomes. Invited Panel Presentation for the Annual NIH Women’s Health Symposium, May 5, 2022.

39. Garland, E.L., Hudak J., & Froeliger, B. (2022). Mindfulness-Oriented Recovery Enhancement Restructures Reward Processing in Opioid Misuse. Society for Biological Psychiatry, New Orleans, April 28, 2022.

40. Garland, E.L. (2022). Mindfulness Occasions Self-Transcendence and Reduces Opioid Misuse by Enhancing Frontal Midline Theta. Science of Consciousness, Tuscon, April, 22, 2022.

41. Garland, E.L., & Hanley, A.W. (2022). Mindfulness-Oriented Recovery Enhancement: A New Neuroscience-Based Treatment for Opioid Misuse, Opioid Use Disorder, and Chronic Pain. RxSummit, Atlanta, April 18, 2022.

42. Garland, E.L. (2021). Mindfulness-based Approaches to Addiction Treatment and Recovery. Invited talk for the Mind and Life Institute, November 13, 2021.

43. Garland, E.L. (2021).  Mindfulness-Oriented Recovery Enhancement Treats Comorbid Chronic Pain, Opioid Misuse, and Psychiatric Disorders by Targeting Hedonic Dysregulation. Invited presentation for the 16th Annual NIH Pain Consortium Symposium on Advances in Pain Research, May 24, 2021.

44. Garland, E.L., Witkiewitz, K., Nock, N., & Su, S. (2021). Bringing Pain and Addiction Researchers Together. Invited Panel Presentation for the Annual NIH HEAL Investigator Meeting, May 19, 2021.

45. Garland, E.L. (2021). Relieving Pain and Opioid Misuse with Mindfulness-Oriented Recovery Enhancement. Grand Rounds to Memorial Sloan Kettering Cancer Center Population Science Research Program, May 18, 2021.

46. Garland, E.L. (2021). Healing the Opioid Crisis with Mindfulness-Oriented Recovery Enhancement: Clinical Efficacy and Neurophysiological Mechanisms. Invited lecture for the National Institutes of Health-National Center on Complementary and Integrative Medicine, May 4, 2021.

47. Garland, E.L. (2021). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse in Primary Care: A Randomized Clinical Trial. Presentation at the annual conference of the Society for General Internal Medicine, April 20, 2021.

48. Garland, E.L. (2021). Mindfulness-Oriented Recovery Enhancement Treats Chronic Pain and Opioid Misuse by Restructuring Reward Processing. Grand Rounds, Department of Psychiatry, Mount Sinai Hospital, New York, March 16, 2021.

49. Garland, E.L. (2021). Mindfulness-Oriented Recovery Enhancement: Leveraging Social Work Science to Create Positive Change in the Opioid Crisis, From Prevention to Intervention. Symposium at the Society for Social Work and Research Annual Conference, January 17, 2021.

50. Garland, E.L. (2020). Mindfulness-Oriented Recovery Enhancement: A Neuroscience-Based Treatment for Opioid Misuse and Addiction. Invited talk to the Utah Attorney General’s Opioid Task Force, December 14, 2020.

51. Garland, E.L. (2020). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse: Clinical Efficacy by Targeting Hedonic Dysregulation. Department of Psychiatry Grand Rounds, Stonybrook University, December 8, 2020.

52. Garland, E.L. (2020). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse: Clinical Efficacy and Biobehavioral Mechanisms. Presentation at the annual conference of the American Psychosomatic Society, December 3, 2020.

53. Garland, E.L. (2020). Mindfulness-Oriented Recovery Enhancement Heals Chronic Pain and Opioid Misuse by Restructuring Reward: From Hedonic Pleasure to Self-Transcendent Meaning. Invited lecture for the Brown University Contemplative Studies Program, December 1, 2020.

54. Garland, E.L. (2020). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse: Clinical Efficacy and Biobehavioral Mechanisms. Invited lecture for the University of Maryland School of Social Work Lunch Time Research Seminar, November 19, 2020.

55. Garland, E.L. (2020). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse: Clinical Efficacy and Biobehavioral Mechanisms. Invited lecture at the Veterans Administration National Pain Research Working Group, October 5, 2020.

56. Garland, E.L. (2020). Self-transcendence as a Mechanism of Mindfulness-Oriented Recovery Enhancement. Invited lecture at University of Southern California Center for Mindfulness Science, June 16, 2020.

57. Garland, E.L. (2020). Targeting Reward Dysregulation Mechanisms of Chronic Pain and Opioid Misuse. Invited talk at National Institutes of Health (NIH) Workshop on Chronic Pain and Opioid Use Disorder, June 1, 2020.

58. Garland, E.L. (2020). Healing the Opioid Crisis with Mindfulness-Based Interventions: How Social Work Research Can Contribute to the NIH HEAL Initiative. Symposium at Society for Social Work and Research 2020 Annual Conference, January 17, 2020, Washington, DC.

59. Garland, E.L., Hanley, A.W., & Hudak, J. (2019). The Role of Mindfulness-Based Interventions in Addressing the Opioid Crisis. Plenary at 2019 Addiction Health Services Research Conference, Park City, UT, October 2, 2019.

60. Garland, E.L. (2019). Mindfulness-Oriented Recovery Enhancement: Targeting Hedonic Dysregulation in Chronic Pain and Addiction. Invited Lecture at Center for Healthy Minds, University of Wisconsin-Madison, October 18, 2019.

61. Garland, E.L. (2019). The Art and Science of Well-Being: Healing the Pathophysiology of Stress, Pain, and Addiction with Mindfulness-Oriented Recovery Enhancement. Plenary at the 2019 Annual Conference of the Institute of Functional Medicine, San Antonio, Texas, May 30, 2019.

62. Garland, E.L. (2019). Mindfulness-Oriented Recovery Enhancement – A New, Neuroscience-Based Treatment for Opioid Misuse, Stress, and Pain. Invited Lecture at New Orleans Veterans Administration Medical Center, New Orleans, LA, April 25, 2019.

63. Garland, E.L. (2019). Mindfulness-Oriented Recovery Enhancement for Addiction, Emotion Dysregulation, and Chronic Pain: Clinical Outcomes and Biobehavioral Mechanisms. Invited Lecture at Florida International University, Miami, FL, March 25, 2019.

64. Garland, E.L. (2019). Mindfulness-Based Interventions for Addiction in Social Work: Novel Therapeutic Mechanisms and Measurement Strategies. Symposium at Society for Social Work and Research 2019 Annual Conference, January 18, 2019, San Francisco, CA.

65. Garland, E.L. (2019). Detecting and Predicting Risk for Prescription Opioid Misuse with an Innovative, Performance-Based Cognitive Measure of Attentional Bias in a Large Sample of Opioid-Treated Pain Patients. Symposium at Society for Social Work and Research 2019 Annual Conference, January 18, 2019, San Francisco, CA.

66. Garland, E.L. (2019). Mindfulness-Oriented Recovery Enhancement: A New, Neuroscience-Based Treatment for Opioid Misuse and Chronic Pain. Grand Rounds to the University of Hawaii Department of Psychiatry, January 4, 2019. Honolulu, HI.

67. Garland, E.L. (2019). Mindfulness-Oriented Recovery Enhancement: A New, Evidence-Based Social Work Intervention for Opioid Misuse and Chronic Pain. Invited talk to the Myron B. Thompson School of Social Work, University of Hawaii, January 2, 2019. Honolulu, HI.

68. Garland, E.L. (2018). Mindfulness-Oriented Recovery Enhancement: A New, Evidence-Based Treatment for Prescription Opioid Misuse. Invited talk to the Utah Opioid Task Force of the Attorney General of Utah, December 4, 2018. Salt Lake City, UT.

69. Garland, E.L. (2018). Mindfulness to Meaning: Healing Hedonic Dysregulation in Addiction, Stress, and Pain with Mindfulness-Oriented Recovery Enhancement. Invited “Master Lecture” to the International Symposium for Contemplative Research, November 10, 2018. Phoenix, AZ.

70. Garland, E.L., Carlson, L., & Segal, S. (2018). To RCT or Not to RCT: Research Methods in Contemplative Clinical Research. Panel presentation to the International Symposium for Contemplative Research, November 10, 2018. Phoenix, AZ.

71. Garland, E.L. (2018). Searching for Nondual Awareness in a Clinical Trial Study. Symposium presentation to the International Symposium for Contemplative Research, November 10, 2018. Phoenix, AZ.

72. Garland, E.L. (2018). Healing Opioid Misuse and Chronic Pain with Mindfulness-Oriented Recovery Enhancement. Invited address to the University of Utah National Advisory Council, November 9, 2018. Salt Lake City, UT.

73. Garland, E.L. (2018). Mind-body Therapies for Acute and Chronic Pain: Efficacy and Mechanisms. Invite plenary lecture to the 15^th annual international conference of the Society for Integrative Oncology, October 29, 2018. Scottsdale, AZ.

74. Garland, E.L. (2018). Randomized Clinical Trial(s) of Brief Mindfulness Versus Hypnotic Suggestion for Reducing Pain and Opioid Use – Time for a National Replication? Invited webinar to the BraveNet Consortium. October 11, 2018.

75. Garland, E.L. (2018). Mindfulness-Oriented Recovery Enhancement Restructures Reward Processing Mechanisms to Remediate Prescription Opioid Misuse. Invited talk at the Alcohol and Drug Abuse Institute, University of Washington, July 9, 2018, Seattle, WA.

76. Zgierska, A., Edwards, R.R., & Garland, E.L. (2018). Addressing the Opioid Epidemic by Maximizing Behavioral Treatment of Chronic Pain. Symposium at International Conference on Opioids, June 10, 2018, Harvard Medical School, Boston, MA.

77. Garland, E.L. (2018). Targeting Hedonic Dysregulation with Mindfulness-Oriented Recovery Enhancement. Invited talk at Addiction Psychiatry Update Conference, June 7, 2018, Salt Lake City, UT.

78. Garland, E.L. (2018). Targeting Hedonic Dysregulation in Pain and Prescription Opioid Misuse with Mindfulness-Oriented Recovery Enhancement. Grand Rounds, University of Utah Department of Psychiatry, June 1, 2018, Salt Lake City, UT.

79. Moeller, S.J., & Garland, E.L. (2018). Implicit behavioral preference for viewing drug versus hedonic images predicts longitudinal change in opioid addiction severity. Poster presentation to the Society for Biological Psychiatry, May 11, 2018, New York, NY.

80. Garland, E.L. (2018). Effects of Mindfulness on Pain and Opioid-Related Problems: Present & Future Prospects for Research and Clinical Application. Symposium at International Congress of Integrative Medicine and Health, May 8, 2018, Baltimore, MD.

81. Garland, E.L. & Hanley, A.W. (2018). Mindfulness-Oriented Recovery Enhancement Increases Interoceptive Awareness in Addictive Behavior and Chronic Pain: Data from Multiple Measurement Approaches. Symposium at International Congress of Integrative Medicine and Health, May 8, 2018, Baltimore, MD.

82. Garland, E.L. & Hanley, A.W. (2018). An Untapped Phenomenology of Mindfulness: Clinical Perspectives and New Measurement Tools for Assessing Meditative Self-Transcendence. Symposium at International Congress of Integrative Medicine and Health, May 9, 2018, Baltimore, MD.

83. Garland, E.L. (2018). Mindfulness-Oriented Recovery Enhancement as a Transdiagnostic Treatment for Pain, Addiction, and Trauma: Clinical Outcomes and Biobehavioral Mechanisms. Invited talk to Southeast Louisiana Veterans Healthcare System PTSD Clinic, April 26, 2018, New Orleans, LA.

84. Garland, E.L., Keefe, F.J., Cherkin, D., Passik, S.J., & Turk, D. (2018). Incorporating Nonpharmacologic Approaches to the Treatment of Opioid Abuse and Chronic Pain Management. Invited talk to Contributions of Social and Behavioral Research in Addressing the Opioid Crisis, National Institutes of Health, March 5, 2018, Bethesda, MD.

85. Garland, E.L. (2018). The Effects of Mindfulness-Oriented Recovery Enhancement on Allostatic Mechanisms in Stress, Pain, and Addiction. Paper presentation to the International Stress and Behavior Society, January 16, 2018, Rodney Bay, St. Lucia.

86. Garland, E.L. (2018). Efficacy of Brief Mindfulness Training and Hypnotic Suggestion for Acute Pain Relief in the Hospital Setting: A Randomized Controlled Trial of Integrative Social Work Interventions. Paper presentation to Society for Social Work and Research 2018 Annual Conference, January 14, 2018, Washington, DC.

87. Garland, E.L. (2018). Effects of Mindfulness-Oriented Recovery Enhancement on Biobehavioral Indices of Reward Processing in Prescription Opioid Misuse and Cigarette Addiction. Symposium at Society for Social Work and Research 2018 Annual Conference, January 13, 2018, Washington, DC.

88. Garland, E.L. (2017). Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain: Clinical Outcomes and Biobehavioral Mechanisms. Grand Rounds, November 13, 2017, George Wahlen Veterans Administration Medical Center, Salt Lake City, UT.

89. Garland, E.L. (2017). Mechanisms of Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse: Targeting Hedonic Dysregulation. Symposium at the American Pain Society, May 19, 2017, Pittsburgh, PA.

90. Garland, E.L. (2017). Targeting Pain and Prescription Opioid Misuse with Mindfulness-Oriented Recovery Enhancement: Biobehavioral Mechanisms and Clinical Application. Invited talk, May 17, 2017, Thomas Jefferson University, Philadelphia, PA.

91. Garland, E.L. (2017). Mechanisms of Mindfulness and their Application to Social Work Practice. Symposium at the Annual Conference of the Society for Social Work and Research. January 16, 2017, New Orleans, LA.

92. Garland, E.L. (2016). Restructuring reward processing with Mindfulness-Oriented Recovery Enhancement. International Symposium for Contemplative Science, November 11, San Diego, CA.

93. Garland, E.L. (2016). Targeting Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse with Mindfulness-Oriented Recovery Enhancement. International Congress for Integrative Medicine and Health, May 20, 2016, Las Vegas, NV. 

94. Garland, E.L. (2016). Mindfulness promotes positive emotion-cognition interactions: Evidence for the Mindfulness-to-Meaning Theory from Research on Mindfulness-Oriented Recovery Enhancement. Symposium at the Annual Conference of the American Psychosomatic Society, March 10, 2016, Denver, CO.

95. Garland, E.L. (2016). Mindfulness-Oriented Recovery Enhancement As a Transdiagnostic Treatment for Co-Occurring Substance Dependence, Traumatic Stress, and Psychiatric Disorders Among Formerly Homeless Persons: Proximal Outcomes from a Cluster Randomized Trial. Annual Conference of the Society for Social Work and Research. January 16, 2016, Washington, DC.

96. Garland, E.L. (2016). Mindfulness-Oriented Recovery Enhancement for Opioid Misuse and Chronic Pain: Neurocognitive and Neuroaffective Findings from a Biobehavioral Clinical Trial. Annual Conference of the Society for Social Work and Research. January 16, 2016, Washington, DC.

97. Garland, E.L. (2015). Social Work and Neuroscience Symposium. Invited Discussant. Boston College, Boston, MA, 10/2-3, 2015

98. Garland, E.L. (2015). Mindfulness-Oriented Recovery Enhancement modulates neurocognitive mechanisms and reward system function in addiction, stress, and pain. Invited presentation, Advances in Meditation Research, September 25, 2015, Sloan Kettering Memorial Hospital, New York, NY. 

99. Garland, E.L. (2015). Mindfulness-Oriented Recovery Enhancement to Reduce Opioid Misuse and Musculoskeletal Pain. 2^nd Annual Pan Pacific Orthopedic Conference, July 24, 2015, Waikaloa, Hawaii.

100. Garland, E.L. (2015). Biobehavioral mechanisms of pain and reward: Implications for mindfulness-based interventions for chronic pain. American Pain Society Annual Meeting, May 14, 2015, Palm Springs, CA.

101. Eichberg, C., Mathew, A., Baddeley, J., Bell, S., LeMay, R., McConnell, P., Garland, E., Froeliger, B. (2015, April).  Mindfulness-Oriented Recovery Enhancement (MORE):  A Novel Smoking-Cessation Treatment Focused on Cognitive Reappraisal and the Savoring of Naturalistic Rewards.  Poster presented at Frontiers in Neuroscience, Charleston, SC.

102. Bell SJ, Dowdle LT, DeVries W, Garland EL, Hanlon CA, Froeliger BE (May 2015). A Preliminary Study Using Interleaved TMS/fMRI to Investigate the Effects of a Mindfulness-Based Intervention on Smoking Cessation. Poster Presented at Society of Biological Psychiatry, Toronto, ON, Canada.

103. Garland, E.L. (2015). Heart rate variability as a translational social work research method. Annual Conference of the Society for Social Work and Research. January 16, 2014, New Orleans, LA.

104. Thomas, E.A., & Garland, E.L. (2015). Dispositional mindfulness and anhedonia among chronic pain patients. Annual Conference of the Society for Social Work and Research. January 16, 2014, New Orleans, LA.

105. Garland, E.L. (2014). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Opioid Misuse: Clinical Impacts and Neurocognitive Mechanisms. 2^nd International Symposium for Contemplative Science, November 2, 2014. Boston, MA.

106. Garland, E.L. (2014). The Role of Mindfulness in Neurocognitive Mechanisms of Addiction with Respect to Alcohol and Opioid Use Disorders. 2^nd International Symposium for Contemplative Science, October 31, 2014. Boston, MA.

107. Garland, E.L. (2014). Treatment Development and Neurocognitive Clinical Research
     on Mindfulness-Based Interventions for Addiction: Mindfulness-Oriented Recovery Enhancement as a Case Study. Invited Breakout Session, Mind and Life Summer Research Institute, June 20, 2014, Garrison, NY.

108. Garland, E.L. (2014). Targeting Chronic Pain and Prescription Opioid Misuse with Mindfulness-Oriented Recovery Enhancement (MORE): Results from a Randomized Controlled Trial. Investigating and Integrating Mindfulness in Medicine, Health Care, and Society 12^th Annual International Scientific Conference for Clinicians, Researchers and Educators, April 4, 2014, Norwood, MA.

109. Garland, E.L., Black, D.S., & Greeson, J.M. (2014). Mindfulness as a Transtherapeutic Approach to Transdiagnostic Mental Processes. Investigating and Integrating Mindfulness in Medicine, Health Care, and Society 12^th Annual International Scientific Conference for Clinicians, Researchers and Educators, April 5, 2014, Norwood, MA.

110. Garland, E.L. (2014). Mindfulness-Oriented Recovery Enhancement for Chronic Pain and Prescription Opioid Misuse: Results from a Randomized Controlled Trial. Annual Conference of the Society for Social Work and Research. January 18, 2014, San Antonio, TX.

111. Garland, E.L. (2013). Biomarkers in Social, Psychological, and Health Science Research. Invited Keynote Lecture, Biomarkers Workshop, Case Western Reserve University, December 6, 2013, Cleveland, OH.

112. Garland, E.L., White, S., Beck, A. (2013). Mindfulness-Oriented Recovery Enhancement for chronic pain and opioid misuse: A promising integrative intervention for cancer survivorship? Annual conference of the Society for Integrative Oncology, October 20. Vancouver, CA. 

113. Garland, E.L. (2013). Targeting chronic pain and prescription opioid misuse with Mindfulness-Oriented Recovery Enhancement: Cognitive, affective, and psychophysiological mechanisms. Pain Management Center Didactic Lecture, September 27. Salt Lake City, UT.

114. Garland, E.L. & Howard, M.O. (2013). Mindfulness-Oriented Recovery Enhancement decreases pain attentional bias in chronic pain patients. Annual Conference for the Center for Mindfulness in Medicine, Health Care, and Society. April 19. Norwood, MA.

115. Garland, E.L., Kiken, L., Palsson, O., Bluth, K., & Gaylord, S.A. (2013). Weekly trajectories of state mindfulness predict increased mindful dispositionality following MBSR: A latent growth curve analysis of state-by-trait interactions. Annual Conference for the Center for Mindfulness in Medicine, Health Care, and Society. April 18. Norwood, MA.

116. Hanley, A.W., Warner, A.R., Dehili, V.M., Canto, A.I., & Garland, E.L. (2013). Brief instruction in an informal mindfulness practice: Washing dishes to wash the dishes. American Psychological Association Annual Conference. Honolulu, HI.

117. Garland, E.L. (2012, Invited). Mindfulness-Oriented Recovery Enhancement: Translating 21^st century behavioral science and neuroscience into an integrative treatment for addiction, stress, and pain. Invited Lecture, Johns Hopkins University School of Medicine, Behavioral Pharmacology Research Unit, Baycrest Medical Center. November 7. Baltimore, MD.

118. Garland, E.L. (2012, Invited). Roundtable discussion on the strategic plan for the Mind and Life Institute. Mind and Life Institute Board Meeting, 25th Annual Mind and Life Conference. October 25. New York, NY.

119. Howard, M.O., & Garland, E.L.  (2012). What are the critical issues in translating research findings from basic neuroscience to the design of intervention and prevention programs for child maltreatment?  Administration for Children, Youth, and Families Neuroscience and Child Maltreatment Expert Panel Meeting, May 3-4, National Institutes of Health, Neuroscience Center Building, Rockville, MD.

120. Garland, E.L., & Zeidan, F. (2012). Mindfulness, cognitive reappraisal, and positive affective style. International Symposium for Contemplative Studies, April 30, Denver, CO.

121. Schuman-Olivier, Z., Garland, E.L., Bowen, S., Brewer, J.,  & Vallejo, Z. (2012). Panel presentation: Mindfulness for difficult populations. International Symposium for Contemplative Studies, April 29, Denver, CO.

122. Garland, E.L. (2012). Trait mindfulness predicts attentional and autonomic regulation of cue-reactivity. International Symposium for Contemplative Studies, April 30, Denver, CO.

123. Howard, M.O., & Garland, E.L. (2012).  New frontiers in the addictions: Recent developments in the behavioral addictions.  Clinical Lecture Series, University of North Carolina at Chapel Hill School of Social Work, April 16.

124. Garland, E.L., Gaylord, S.A., Palsson, O., Faurot, K., Mann, J.D., & Whitehead, B. (2012, April 13). Mindfulness Training Targets Cognitive-Affective Mechanisms in Irritable Bowel Syndrome by Modulating Emotional Processing of Pain Sensations. Society for Behavioral Medicine, 2012, New Orleans.

125. Garland, E.L., Gaylord, S.A., Palsson, O., Faurot, K., Mann, J.D., & Whitehead, B. (2012, March 30). Mindfulness Training Ameliorates IBS by Promoting Non-Reactivity and Reduced Affective Processing of Pain Sensations. University of Massachusetts, Center for Mindfulness, 2012, Boston.

126. Garland, E.L., & Roberts-Lewis, A. (2012, January 12). Differential roles of mindfulness and thought suppression in post-traumatic stress symptoms and craving. Society for Social Work and Research 2012, Washington, DC.

127. Garland, E.L., Kelly, A., & Howard, M.O. (2012, January 13). Trauma history moderates the effect of mindfulness training and social support on the alcohol attentional bias. Society for Social Work and Research 2012, Washington, DC.

128. Garland, E.L., Greeson, J.M., & Howard, M.O. (2011, November 11). Salutary effects of mindfulness training on alcohol attentional bias moderated by trauma history. 45^th Annual Convention of the Association for Behavioral and Cognitive Therapies 2011, Toronto, CA.

129. Garland, E.L. (2011, September 13). Trait mindfulness predicts attentional and autonomic cue-reactivity. Society for Psychophysiological Research, Westin Marriot, Boston, MA. Published in Psychophysiology, 48, Supplement S1, S37.

130. Garland, E.L. (2011, September 2). Cognitive-emotional mechanisms in attentional and autonomic regulation of cue-reactivity: A transdiagnostic framework? College of Social Work Research “Brown Bag,” Tallahassee, FL.

131. Howard, M.O., & Garland, E.L. (2011, June 22). Phenomenology, natural history, and sociocultural aspects of inhalant use and inhalant intoxication. College on Problems of Drug Dependence Symposium on Volatile Solvent Misuse: A Global Call for Action, Hollywood, FL.

132. Gaylord, S.A., Palsson, O., Garland, E.L., Faurot, K., Mann, J.D., & Whitehead, B.W. (2011, May 9). Therapeutic impact of mindfulness meditation on irritable bowel syndrome: Results of a randomized controlled trial. Digestive Disease Week 2011, Chicago, IL.

133. Garland, E.L., Gaylord, S.A., & Fredrickson, B.L. (2011, January 15). Positive reappraisal mediates the stress reductive effects of mindfulness: An upward spiral process. Society for Social Work and Research 2011, Tampa, FL.

134. Garland, E.L., Gaylord, S.A., Palsson, O., Faurot, K., Mann, J.D., & Whitehead, W. (2011, January 14). Mindfulness training targets cognitive and affective mechanisms to reduce illness severity and improve quality of life among women with irritable bowel syndrome. Society for Social Work and Research 2011, Tampa, FL.

135. Howard, M.O. & Garland, E.L. (2010, November 6). Detecting and treating co-occurring substance use disorders and behavioral addictions in women with eating disorders. The 6th Annual Conference on Eating Disorders: The Mind-Body Solution. Women’s Mental Health and Wellness, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.

136. Garland, E.L. (2010, June 4). Mindfulness modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: A randomized controlled pilot trial. Paper presentation at the Department of Physical Medicine and Rehabilitation Research Day, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC. 

137. Garland, E.L. (2010, February 19). Mindfulness-oriented recovery enhancement: A targeted treatment for drug and alcohol dependence. Presentation to Triangle Residential Options for Substance Abusers (TROSA), Durham, NC.

138. Garland, E.L., Gaylord, S.A., Boettiger, C.A., Roberts, A.C., Rounds, K.A., & Howard, M.O. (2010, January 16). Biopsychosocial assessment of a mindfulness-oriented intervention for stress-precipitated alcohol dependence: A pilot randomized controlled trial. Paper presentation at the 14th Annual Society for Social Work Research Conference, San Francisco.

139. Garland, E.L. (2010, January 11). Structural equation modeling: Probing therapeutic mechanisms of CAM interventions. Presentation to the Consortium for Academic Health Centers in Integrative Medicine, Research Working Group teleconference. 

140. Gaylord, S.A., & Garland. E.L. (2009, December 11). Mindfulness-based interventions: Theory, evidence, and clinical application. Presentation at the Complementary and Alternative Therapy Conference, The University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, NC. 

141. Garland, E.L. (2009, November 23). Mindfulness, stress, and health. Presentation at University of North Carolina, School of Social Work, Chapel Hill, NC.

142. Garland, E., Gaylord, S., Boettiger, C., & Howard, M. (2009, June 7). Mindfulness impacts cognitive-affective mechanisms of alcohol dependence: A randomized controlled pilot trial. Poster presentation at the Mind and Life Summer Research Institute, Garrison, NY.

143. Gaylord, S., Palsson, O., Faurot, K., Garland, E., Coble, B., Mann, D., & Whitehead, B. (2009, May 12). Dispositional mindfulness is associated with psychological symptoms accompanying irritable bowel syndrome. Poster presentation at the North American Research Conference on Complementary & Integrative Medicine, Minneapolis, MN.

144. Garland, E., Boettiger, C., Gaylord, S., West, V., & Howard, M. (2009, March 3). The inverse relationship between mindfulness, alcohol attentional bias, and cue reactivity. University of North Carolina Research Day 2009, Chapel Hill, NC.

145. Gaylord, S., Palsson, O., Faurot, K., Garland, E., Coble, B., Mann, D., & Whitehead, B. (2008, October 4). Dispositional mindfulness is associated with psychological symptoms accompanying irritable bowel syndrome. Biopsychosocial Gastrointestinal Research Day 2008 at University of North Carolina, Chapel Hill, NC.

146. Garland, E. (2008, August 15). Evidence-based practice in Social Work. University of North Carolina – Chapel Hill MSW Workshop, Chapel Hill, NC. 

147. Garland, E. (2008, June 4). Mindfulness in Social Work: State of the art and state of the science. University of North Carolina – Chapel Hill MSW Field Instructor Appreciation Workshop. Chapel Hill, NC. 

148. Garland, E. & Greeson, J. (2007, November 19). Mindfulness: Theoretical and empirical perspectives on the self-regulation of brain and body. Presentation to the Health Psychology Department, Duke Integrative Medicine, Durham, NC.

149. Garland, E. (2007, November 6). Mindfulness in positive reappraisal: A metacognitive focal point for psychotherapeutic intervention. Presentation at the Theory Construction and Research Methodology Workshop of the National Council of Family Relations, Pittsburgh, PA.

150. Garland, E.  (2006, March 22 & 29).   Enhancing developmental resilience through self-regulation skill instruction.  Clinical staff training at SUWS of the Carolinas, Old Fort, NC.

151. Garland, E.  (2005, November 16 & 23).  Clarifying our mission: The therapeutic application of a search and rescue metaphor to work with at-risk adolescents.  Clinical staff training at SUWS of the Carolinas, Old Fort, NC.

152. Garland, E.  (2005, September 7 & 14).  Isomorphism and the promotion of healthy child socialization.  Clinical staff training at SUWS of the Carolinas, Old Fort, NC.

153. Garland, E. (2005, February 9 & 16).  Isomorphism and metaphor: Wilderness experience as analogue for life experience.  Clinical staff training at SUWS of the Carolinas, Old Fort, NC.

154. Garland, E. (2003, September 17 & 24).  Group therapy tactics.  Clinical staff training at SUWS of the Carolinas, Old Fort, NC.

155. Howsare, J., Garland, E., & Klein, H. (2003, May 12).  Promoting healthy adaptation of children following divorce.  Presentation at the Fourteenth Annual Training Conference of Central West Virginia Aging Services, Stonewall Jackson Resort, Roanoke, WV.

156. Howsare, J., & Garland, E. (2003, April 18).  Promoting healthy adaptation of children following divorce.  Presentation at the West Virginia NASW Continuing Education Conference, Charleston Civic Center, Charleston, WV.
     
157. Garland, E., & Klein, H. (2003, March 14).  Cultural diversity training seminar for psychiatry residents.  Grand Rounds at the West Virginia University Department of Behavior Medicine & Psychiatry, Morgantown, WV.

EDITORIAL ACTIVITIES

NIH STUDY SECTION

NIH ADVISORY ROLE

CONSULTANT, DSM-V Substance-Related Disorders Workgroup, Inhalant-Related Disorders, 2010

ASSOCIATE EDITOR

EDITORIAL REVIEW BOARD

ASSISTANT EDITOR OF SOCIAL WORK

AD-HOC REVIEWER

RESEARCH EXPERIENCE

CLINICAL EXPERIENCE

TEACHING EXPERIENCE

UNDERGRADUATE RESEARCH STUDENTS

Undergraduate Research Opportunity Program (UROP), Florida State University:

• Hillary Gale, Sociology (Fall 2011)
• Corrie Hodges, Biological Sciences (Fall 2012)
• Kelsey Youngman, BA in Psychology (Spring 2012)
• Ann Benitez, BA in Nursing (Fall 2012)
• Deidre Krzanowski, BA in Psychology (Spring 2013)
• Hillary Gale, BA in Sociology (Spring 2013)

Undergraduate Research Opportunity Program (UROP), University of Utah:

• Mary Catherine Gebhard, BA in Psychology (Fall 2015)
• Amy Kenney, BSW (Spring 2015)
• Madeline Odette, BA in Chemistry (Fall 2016)
• Martha Mendes, BSW (Spring 2016)
• Brett Crump, BSW (Fall 2017)
• Hannah Louise Landicho, Pre-Med (Fall 2019)

Other Undergraduate Reseachers:

• Raha Mehrkish, Psychology (Fall 2022)

MASTERS STUDENTS

• Directed Independent Study, Alana Frazier, MSW Student – Hypnosis and Strategic Therapy (UNC; 2010)
• Summer Research Fellowship, Alrick Drummond, MS, College of Medicine (FSU; 2011)
• Directed Independent Study, Kaitlyn Suveg, MSW student – Opioid Addiction and Chronic Pain (FSU; 2011)
• Directed Independent Study, Shella Scully-Hilbert, MSW student – Psychopathy and At-Risk Youth (FSU; 2012)
• Directed Independent Study, Daniel Dunleavy, MSW student – Positive Coping and Resilience (FSU; 2013)
• Directed Independent Study, Jenna Scott, Ph.D. student in Marriage and Family Therapy – Mindfulness-based Family Therapy to Reduce Parent-Child Emotion Dysregulation (FSU; 2013)
• Martha Mendes, MSW Student – Mindfulness and Opioid Misuse (University of Utah; 2016)
• Shandlie Bodily, MSW (University of Utah; 2021)
• Ayaka Lingard, MSW – Mindfulness, Placebo, and Knee Surgery (University of Utah; 2022)
• Sarah Reynolds, MSW – Mindfulness, Chronic Pain, and Opioid Use (University of Utah; 2022)
• Madeleine Odette, Masters in Public Health – Alcohol and Opioid Craving (University of Utah; 2023)
• Elka Cucub, MSW – Phenomenology of Self-Transcendence (University of Chicago; 2023)
• Ruthie Schnitt, MSW – Mindfulness, Placebo, and Pain (University of Utah; 2023)
• Jeremy Horn, MSW – Brief Mindfulness for Total Knee Arthoplasty (University of Utah; 2023)
• Lucy Hayes Allotey, MSW – Mindfulness, Chronic Pain, and Opioid Misuse (University of Utah; 2023)
• Samantha Vaca St. Clair, Counseling – Mindfulness, Placebo, and Pain (University of Utah; 2023)
• Topher Rasmussen, MSW – Mindfulness and Motivational Interviewing for OUD (University of Utah; 2023)

DOCTORAL STUDENT ADVISEES

• Amber Kelly, MSW, LCSW, Smith College of Social Work, 2010
• Kristin Carter, MSW, FSU College of Social Work, 2011
• Elizabeth Thomas, University of Utah College of Social Work, 2013
• Sarah Reese, University of Utah College of Social Work, 2015
• Michael Riquino, University of Utah College of Social Work, 2015
• Anne Baker, University of Utah College of Social Work, 2016
• Aryana Bryan, University of Utah College of Social Work, 2017

DOCTORAL RESEARCH OR DISSERTATION/QUALIFYING EXAMINATION COMMITTEES

• Daniel Quintana, Ph.D. in Psychology, University of Sydney, Australia (2013) – The impact of alcohol use, self-regulation, and oxytocin administration on heart rate variability 
• Amber Kelly, Ph.D. in Social Work, Smith College (2014) – Trauma-informed mindfulness based stress reduction: development of a model and an application with a sample of women who have survived interpersonal trauma 
• Kristin Richards, Ph.D. in Social Work, FSU College of Social Work (2016)
• Vivien Li, Ph.D. in Social Work, University of North Carolina at Chapel Hill (2016) – Mindfulness-Oriented Recovery Enhancement for Video Game Addiction in U.S. Emerging Adults 
• Samantha Brown, Ph.D. in Social Work, University of Denver (2016) –  A Mindfulness-Based Intervention to Improve Family Functioning among Child Welfare-Involved Families with Substance Use 
• Christy Tronnier, Ph.D. in Social Work –  Evaluating the Attachment Dimensions of Internet Gaming Disorder and the Outcomes of a Randomized Controlled Trial of Mindfulness-Oriented Recovery Enhancement 
• Elizabeth Thomas, Ph.D. in Social Work, Smith College (2017) – Targeting Biobehavioral Mechanisms in Obesity among Cancer Survivors with Mindfulness-Oriented Recovery Enhancement, University of Utah (2017)
• Patrick McConnell, Ph.D. in Neuroscience, Medical University of South Carolina (2018)
• Michael Riquino, Ph.D., in Social Work, University of Utah (2019) – A Mixed Methods Investigation of Attention and Mindfulness Among Young Adults with a History of Nonsuicidal Self-Injury 
• Sarah Priddy, Ph.D., in Social Work, University of Utah (2020) – Targeting the Underlying Mechanisms of Prenatal Opioid Use and Child Well-Being with Mindfulness-Oriented Recovery Enhancement 
• Anne Baker, Ph.D., in Social Work, University of Utah (2021) – A Psychoneuroimmunological Investigation of Chronic Pain and Risk for Opioid Misuse 
• Adi Shoham, Ph.D., in Clinical Psychology, University of Haifa, Israel (2019) – Understanding the Salutary Mechanisms of Present Moment Attention and Awareness: Intensive Experience Sampling Study of Mindfulness Training
• Noga Avidad, Ph.D., in Clinical Psychology, University of Haifa, Israel (2023) – Dynamical Systems Theory and Study of Mindfulness
• Bhanu Gullapalli, Ph.D. in Computer Science, UC San Diego (to be completed in 2024)

MEDICAL STUDENTS AND RESIDENTS

• Kevin Byrne, MD, Psychiatry, University of Utah (2021) – Ketamine-Assisted Psychotherapy for Opioid Use Disorder
• Karishma Shah, MD-PhD, University of Utah (2021) – Psychophysiology and Chronic Pain

INTERNATIONAL RECOGNITION AND SERVICE

Advisory Board Member, FDA-Sponsored Advisory Board of Pacific Northwest Evidence-based Practice Center – “The Development of Clinical Practice Guidelines for the Assessment and Management of Acute Low Back Pain” (2024)

Advisory Council Member, International Society for Contemplative Research, 2023-present

Member, International Delphi Consensus Panel to Develop International Guidelines for Cognitive Remediation Interventions for Addiction, International Society of Addiction Medicine

Advisory Board Member, Joint American Society of Clinical Oncology-Society for Integrative Oncology Expert Panel to Develop Guideline for “Integrative Approach to Pain Management” (2020)

Advisory Member, NIH HEAL Multidisciplinary Working Group, NIH, 2019-present

Chair, Research Working Group, Academic Consortium for Integrative Medicine and Health, 2018 

Vice Chair, Research Working Group, Academic Consortium for Integrative Medicine and Health, 2017 

Grand Challenges of Social Work Workgroup on Health Services/Systems, member, 2017

Steering Committee – University of Utah Representative, Academic Consortium for Integrative Medicine and Health, 2016 – present

Scientific Advisory Committee Member, Concordance Institute for Advancing Social Justice, 2016 – present

Distinguished Fellow, National Academies of Practice, 2015

Invited Reviewer of scientific abstracts for the 2016 International Symposium of Contemplative Studies

Inaugural Member, Research Committee, American Mindfulness Research Association, 2014

Member, Social Work and Neuroscience Symposium, Boston College, 2015

Invited Reviewer of scientific abstracts for the 2015 Society for Integrative Oncology conference

Member, Research Methodology Workgroup, Society for Integrative Oncology, 2013

Research Fellow, National Center for Veterans Studies, Salt Lake City, UT, 2013

Invited Reviewer of Research Fellow Applications for the Mind and Life Summer Research Institute

Invited Reviewer of scientific abstracts for the 2014 and 2016 International Symposia of Contemplative Studies

Member, planning committee for pre-conference workshop on Craving, Desire, and Addiction. 2^nd annual International Symposium for Contemplative Studies, Boston, MA, October 2014.

Member, task force on the Contemplative Science of Craving, Desire, and Addiction, Mind and Life Institute, Amherst, MA, 2012

Fellow, Mind and Life Institute, 2012

Invited Reviewer, National Health and Medical Research Council, Australia, 2012 grant round

Invited Reviewer, Flanders Research Foundation (Fonds Wetenschappelijk Onderzoek – Vlaanderen, FWO), Belgium, 2012 grant round

SERVICE TO THE UNIVERSITY

Opioid Research Task Force – University of Utah, 2018 – present

Opioid and Medical Marijuana Task Force – University of Utah, 2016 – present

Chronic Pain Task Force – University of Utah, 2017 – present

Associate Dean for Research – College of Social Work, University of Utah, 2015 – present

Faculty Search Committee, College of Social Work, University of Utah, 2014, 2015, 2017

Dean’s Search Committee, College of Social Work, University of Utah, 2014, 2016

Strategic Planning Committee, College of Social Work, University of Utah, 2017

PhD Program Statistics and Research Sub-Committee, College of Social Work, University of Utah, 2016 – present

Travel Committee, College of Social Work, University of Utah, 2015 – 2016

Speaker – “Mindfulness and Wellness for Provider and Patient”, University of Utah Community Clinics, 2015

Family Medicine Resident Training, seminar on mindfulness, Fall 2015

Integrated Behavioral Health in Primary Care Planning, University of Utah Community Clinics, 2015

Clinical Integration Platform Task Force, Huntsman Cancer Institute, University of Utah, 2015

Office for Global Engagement Scholarship Committee, University of Utah, 2015-2016

PhD Committee, College of Social Work, University of Utah, 2013 – present

Speaker – “Biobehavioral Clinical Research,” University of Utah School of Nursing T32 Fellowship Program, Spring 2015

Bridge Training Clinic Planning Committee, College of Social Work, University of Utah, 2013-2014

Research Fellow, National Center for Veterans Studies, University of Utah

Associate Director of Integrative Medicine, Supportive Oncology and Survivorship Program, Huntsman Cancer Institute, University of Utah

Assistant Director, Trinity Institute for the Addictions, Fall 2012

Research Committee, College of Social Work, FSU, Fall 2011, Spring 2012, Fall 2012

Academic Affairs Committee, College of Social Work, FSU, Fall 2011, Spring 2012, Fall 2012

Interdisciplinary Health Sciences Clinic Planning Committee, College of Social Work, FSU, Fall 2011

Trinity Institute for the Addictions Planning Committee, College of Social Work, FSU Fall 2010, Spring 2011, Fall 2012

Interprofessional Case Conference Planning Committee and Member – FSU College of Medicine, Spring 2011

Speaker – “Chronic Pain Treatment with Mindfulness Training, Cognitive Behavioral Therapy, and Clinical Hypnosis” – FSU Counseling Center Internship Training, Spring 2012

Speaker – “Mind-Body Therapies” – Medicine & Behavior Course, Eron Manusov, College of Medicine, FSU Spring 2011

Interview Subject – BSW Interviewing and Recording course, College of Social Work, FSU Fall 2010

Presentation – “Developing a Research Agenda” 

• Quantitative Research Course, Mary Jane Taylor, College of Social Work, University of Utah, Fall 2013
• Doctoral Research Course, Linda Vinton, College of Social Work, FSU Fall 2010; La Tonya Noel, Fall 2011

Presentation – “The Academic Social Work Job Market” 

• FSU Doctoral Student Brown Bag, Nov 15, 2010

Field Instructor – School of Social Work, University of North Carolina, Chapel Hill

Field Placement: UNC Program on Integrative Medicine, Behavioral Medicine

• Emily Fitch, 2007 – 2008
• Noah Martinson, 2008 – 2009

SERVICE TO THE PROFESSION

Abstract Reviewer, 2015 Annual Conference of the Society for Integrative Oncology

NIH T-32 NCCAM Fellowship Advisory Committee Member – Program on Integrative Medicine, Department of Physical Medicine & Rehabilitation, University of North Carolina at Chapel Hill, 2012 – present

Mind and Life Summer Research Institute Fellowship Reviewer, 2013

Abstract Reviewer, 2013 Annual Conference of the Society for Social Work and Research

Mind and Life Fellow, Strategic Planning Meeting of the Mind and Life Institute Board of Directors, 2012

SERVICE TO THE COMMUNITY

Special Advisor, Utah Opioid Task Force, Utah Attorney General’s Office

Mindfulness and Wellness for the Provider and Patient – CME presentation for Providers at the University of Utah Primary Care Clinics. September 16, 2015.

Training for Utah Mental Health Community “Generations Conference” – Mindfulness-Oriented Recovery Enhancement: Neurocognitive mechanisms and clinical tactics. March 21, 2015.

Training for Utah NASW Fall professional education series – Mindfulness-Oriented Recovery Enhancement for addiction, stress, and pain. November 8, 2013.

Training for Huntsman Cancer Institute Patient and Family Support Team  – Mindfulness-Oriented Recovery Enhancement: A promising integrative oncology intervention. October 15, 2013.

Advisory Board Member and Consultant – Tallahassee Memorial Hospital Recovery Center and Behavioral Health Center, 2012 – present.

Speaker, Big Bend Mental Health Coalition, delivered talk entitled “Mindfulness Training for Pain and Addiction: Effects on Brain and Body,” Tallahassee, May 2012

Board Member – Medical Hypnosis Foundation, Advisory Board, Raleigh, NC, 2009 – 2010

Support Group Leader – Social Support for Women with Irritable Bowel Syndrome, Chapel Hill, NC, 2007 – 2008

Trainer – Social Support for Integrative Diabetes Management, Prospect Hill, NC, 2007

PROFESSIONAL TRAINING

Event Related Potential Analysis Bootcamp, Society for Psychophysiological Research, Boston, MA, 2012

Latent Trajectory/Growth Curve Analysis: A Structural Equation Modeling Approach,

ICPSR Summer Program in Quantitative Methods of Social Research, Chapel Hill, NC, 2009

Heart Rate Variability Analysis – Biobehavioral Laboratory, School of Nursing, University of Chapel Hill, NC, 2008

Enzyme-Linked Immunoassay for Salivary Cortisol Analysis – Biobehavioral Laboratory, School of Nursing, University of Chapel Hill, NC, 2008

Hierarchical and Multilevel Linear Modeling, ICPSR Summer Program in Quantitative Methods of Social Research, Chapel Hill, NC, 2007

Functional Magnetic Resonance Imaging (fMRI) Course – Brain Imaging and Analysis Center, Duke University, Durham, NC, 2007

Mind and Life Summer Research Institute – Garrison Institute, Garrison, NY, 2007, 2008, 2009

PROFESSIONAL CERTIFICATIONS/CREDENTIALS

Credentialed Provider, University of Utah Health Care, Division of Oncology, Department of Internal Medicine, 2013 – present

Utah Licensed Clinical Social Work (LCSW), 2013-present

Florida Licensed Clinical Social Worker (LCSW), 2010 – 2013

North Carolina Licensed Clinical Social Worker (LCSW), 2005 – 2012

Certified in Clinical Hypnosis, American Society of Clinical Hypnosis, 2005 – present

Approved Consultant in Clinical Hypnosis, American Society of Clinical Hypnosis, 2012 – present

PAST AND PRESENT PROFESSIONAL MEMBERSHIPS

US Association for the Study of Pain

International Society of Addiction Medicine

International Society for Contemplative Research

Academic Consortium for Integrative Medicine and Health

New York Academy of Sciences

International Association for the Study of Pain

National Academies of Practice

American Mindfulness Research Association

Society for Social Work and Research

National Association of Social Workers